JPH0959295A - Steroid derivative - Google Patents

Steroid derivative

Info

Publication number
JPH0959295A
JPH0959295A JP8115165A JP11516596A JPH0959295A JP H0959295 A JPH0959295 A JP H0959295A JP 8115165 A JP8115165 A JP 8115165A JP 11516596 A JP11516596 A JP 11516596A JP H0959295 A JPH0959295 A JP H0959295A
Authority
JP
Japan
Prior art keywords
compound
group
ethyl acetate
acid
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8115165A
Other languages
Japanese (ja)
Inventor
Hisaya Wada
久弥 和田
Hajime Asanuma
肇 浅沼
Chihiro Yokoo
千尋 横尾
Taiji Yamada
泰司 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP8115165A priority Critical patent/JPH0959295A/en
Publication of JPH0959295A publication Critical patent/JPH0959295A/en
Pending legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a new steroid derivative stereoselectively synthesizable in high efficiency by an organic synthetic chemical means, having simplified structure of the side chain at 17 position, exhibiting excellent antitumor action and useful as an antitumor agent, etc. SOLUTION: The objective compound is a new steroid derivative (salt) expressed by formula I (R is a 1-13C alkyl; A is hydroxyl group or a group easily hydrolyzable to form hydroxyl group; X and Y together form oxo or a 2-3C alkylenedioxy or X and Y are each H, hydroxy, a 1-5C alkoxy or a group easily hydrolyzable to form hydroxyl group; Y is H when X is hydroxyl group, etc.; X is H when Y is hydroxyl group, etc.; Y is a 1-5C alkoxy when X is a 1-5C alkoxy). The compound is useful as an antitumor agent, etc. The compound can be synthesized in high efficiency and stereoselectivity by using a steroid expressed by formula II as a starting substance and subjecting the substance to various reactions using organic synthetic chemical means.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、抗腫瘍作用を有す
る新規なステロイド誘導体に関する。
TECHNICAL FIELD The present invention relates to a novel steroid derivative having an antitumor effect.

【0002】[0002]

【従来の技術】本発明化合物と類似の構造を有する物質
として、特開平7−70171号公報に記載のXestospo
ngia属海綿から単離された化合物(以下、化合物Cと称
する)が知られている。化合物Cは、優れた抗腫瘍作用
を有しており新規抗癌剤として期待される。しかしなが
ら、海洋天然物由来であることから資源確保に問題があ
り大量安定供給は困難であった。また、化合物Cの17
位側鎖中には5個の不斉炭素が存在しているため、その
効率的な立体選択的合成は至難であった。
As a substance having a structure similar to that of the compound of the present invention, Xestospo described in JP-A-7-70171.
A compound isolated from sponge of the genus ngia (hereinafter referred to as compound C) is known. Compound C has an excellent antitumor effect and is expected as a novel anticancer agent. However, since it is derived from marine natural products, there was a problem in securing resources and it was difficult to provide a large-scale stable supply. In addition, 17 of compound C
Since five asymmetric carbons are present in the side chain, efficient stereoselective synthesis was extremely difficult.

【0003】[0003]

【発明が解決しようとする課題】本発明は、有機合成化
学的手法により効率良く且つ立体選択的に合成できる抗
腫瘍作用を有する新規ステロイド化合物を提供すること
を目的とする。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a novel steroid compound having an antitumor effect, which can be efficiently and stereoselectively synthesized by a synthetic organic chemical method.

【0004】[0004]

【課題を解決するための手段】本発明者らは化合物Cの
17位側鎖の簡素化を鋭意研究した結果、17位側鎖の
不斉炭素を2個に減らした本発明の新規ステロイド誘導
体を合成し、これらが化合物Cと同等の抗腫瘍効果を示
すことを見いだし、本発明を完成した。
Means for Solving the Problems As a result of intensive studies on the simplification of the 17-position side chain of compound C, the present inventors have found that the novel steroid derivative of the present invention in which the 17-position side chain has asymmetric carbon atoms reduced to two. Were found to exhibit an antitumor effect equivalent to that of Compound C, and the present invention was completed.

【0005】以下、本発明を説明する。Hereinafter, the present invention will be described.

【0006】本発明は、式(I)The present invention has the formula (I)

【0007】[0007]

【化2】 Embedded image

【0008】(式中、Rは炭素原子数1〜13のアルキ
ル基を示し、Aは水酸基または容易に加水分解されて水
酸基になる基を示し、XとYは一緒になってオキソ基又
は炭素原子数2もしくは3のアルキレンジオキシ基を示
すか、X及びYはそれぞれ水素原子、水酸基、炭素原子
数1〜5のアルコキシ基又は容易に加水分解されて水酸
基になる基を示す。但し、Xが水酸基又は容易に加水分
解されて水酸基になる基のときYは水素原子であり、Y
が水酸基又は容易に加水分解されて水酸基になる基のと
きXは水素原子である。また、Xが炭素原子数1〜5の
アルコキシ基のときYは炭素原子数1〜5のアルコキシ
基である。)で表わされるステロイド誘導体及びその医
薬上許容される塩である。
(Wherein R represents an alkyl group having 1 to 13 carbon atoms, A represents a hydroxyl group or a group which is easily hydrolyzed to form a hydroxyl group, and X and Y together form an oxo group or a carbon group. It represents an alkylenedioxy group having 2 or 3 atoms, or X and Y each represent a hydrogen atom, a hydroxyl group, an alkoxy group having 1 to 5 carbon atoms, or a group which is easily hydrolyzed to form a hydroxyl group. Is a hydroxyl group or a group easily hydrolyzed to a hydroxyl group, Y is a hydrogen atom, and Y is
X is a hydrogen atom when is a hydroxyl group or a group which is easily hydrolyzed to a hydroxyl group. When X is an alkoxy group having 1 to 5 carbon atoms, Y is an alkoxy group having 1 to 5 carbon atoms. ) And a pharmaceutically acceptable salt thereof.

【0009】[0009]

【発明の実施の形態】本発明において、アルキル基とは
直鎖状又は分枝鎖状のアルキル基を意味し、例えばメチ
ル基、エチル基、プロピル基、イソプロピル基、ブチル
基、イソブチル基などを挙げることができる。このうち
好ましくはイソブチル基である。
BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, the alkyl group means a linear or branched alkyl group, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group and the like. Can be mentioned. Of these, an isobutyl group is preferred.

【0010】容易に加水分解されて水酸基になる基と
は、酸又はアルカリによる常用の加水分解反応により容
易に加水分解されて水酸基になる基を意味し、例えばア
ルカノイルオキシ基、置換アルカノイルオキシ基、スル
ホオキシ基、ホスホノオキシ基などが挙げられる。アル
カノイルオキシ基としては、例えばアセトキシ基、プロ
ピオニルオキシ基、ブチリルオキシ基、イソブチリルオ
キシ基などが挙げられる。このうち好ましくはアセトキ
シ基である。置換アルカノイルオキシ基としては、例え
ばN,N−ジメチルグリシルオキシ基、N,N−ジエチル
グリシルオキシ基、3−(N,N−ジメチルアミノ)プ
ロピオニルオキシ基、3−(N,N−ジエチルアミノ)
プロピオニルオキシ基、4−(N,N−ジメチルアミ
ノ)ブチリルオキシ基、スクシニルオキシ基、グルタリ
ルオキシ基、3−スルホプロピオニルオキシ基などが挙
げられる。このうち好ましくはN,N−ジメチルグリシ
ルオキシ基、N,N−ジエチルグリシルオキシ基、スク
シニルオキシ基である。
The group easily hydrolyzed to a hydroxyl group means a group which is easily hydrolyzed to a hydroxyl group by a conventional hydrolysis reaction with an acid or an alkali, and examples thereof include an alkanoyloxy group and a substituted alkanoyloxy group. Examples thereof include a sulfooxy group and a phosphonooxy group. Examples of the alkanoyloxy group include an acetoxy group, a propionyloxy group, a butyryloxy group and an isobutyryloxy group. Of these, acetoxy group is preferred. Examples of the substituted alkanoyloxy group include N, N-dimethylglycyloxy group, N, N-diethylglycyloxy group, 3- (N, N-dimethylamino) propionyloxy group, 3- (N, N-diethylamino group. )
Examples include propionyloxy group, 4- (N, N-dimethylamino) butyryloxy group, succinyloxy group, glutaryloxy group, 3-sulfopropionyloxy group and the like. Among these, N, N-dimethylglycyloxy group, N, N-diethylglycyloxy group and succinyloxy group are preferable.

【0011】本発明における医薬上許容される塩とは、
例えば塩酸、臭化水素酸、ヨウ化水素酸、硫酸、硝酸、
りん酸などの無機酸との塩、ギ酸、酢酸、プロピオン
酸、乳酸、酒石酸、フマル酸、マレイン酸、クエン酸、
ラクトビオン酸、カンファースルホン酸、イセチオン
酸、コハク酸、アスコルビン酸、リンゴ酸、サリチル
酸、トリフルオロ酢酸、メタンスルホン酸、パラトルエ
ンスルホン酸などの有機酸との塩、またはナトリウムな
どのアルカリ金属との塩、マグネシウム、カルシウムな
どのアルカリ土類金属との塩、アンモニウム塩、トリエ
チルアミンなどのアルキルアミン類との塩などを挙げる
ことができる。
The pharmaceutically acceptable salt in the present invention means
For example, hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, nitric acid,
Salts with inorganic acids such as phosphoric acid, formic acid, acetic acid, propionic acid, lactic acid, tartaric acid, fumaric acid, maleic acid, citric acid,
Lactobionic acid, camphorsulfonic acid, isethionic acid, succinic acid, ascorbic acid, malic acid, salicylic acid, trifluoroacetic acid, methanesulfonic acid, salts with organic acids such as paratoluenesulfonic acid, or salts with alkali metals such as sodium , Salts with alkaline earth metals such as magnesium and calcium, ammonium salts, salts with alkylamines such as triethylamine, and the like.

【0012】本発明の式(I)で示される化合物は、文
献(Chem.Ber.,第100巻,第464頁,1967
年)記載のステロイド誘導体3β,12β−ジヒドロキ
シ−5α−プレグナン−20−オン(1)を出発原料と
して用い、下記の図1〜図9に示す製法に従って合成す
ることができる。以下に本発明化合物の製造法を順に概
説する。
The compound represented by the formula (I) of the present invention can be prepared according to the method described in the literature (Chem. Ber., 100, 464, 1967).
The steroid derivative 3β, 12β-dihydroxy-5α-pregnan-20-one (1) described in (1) is used as a starting material and can be synthesized according to the production methods shown in FIGS. 1 to 9 below. The production method of the compound of the present invention will be outlined below in order.

【0013】まず、本発明の式(I)で示される化合物
のうち、Aが水酸基であり、XとYは一緒になってオキ
ソ基又は炭素原子数2もしくは3のアルキレンジオキシ
基であるか、X及びYはそれぞれ水素原子、水酸基、炭
素原子数1〜5のアルコキシ基である本発明化合物の製
法を概説する(図1〜図6)。
First, in the compound represented by the formula (I) of the present invention, is A a hydroxyl group, and X and Y together are an oxo group or an alkylenedioxy group having 2 or 3 carbon atoms. , X and Y respectively represent a hydrogen atom, a hydroxyl group, and an alkoxy group having 1 to 5 carbon atoms, which will be outlined below (FIGS. 1 to 6).

【0014】[0014]

【化3】 Embedded image

【0015】[0015]

【化4】 Embedded image

【0016】[0016]

【化5】 Embedded image

【0017】[0017]

【化6】 [Chemical 6]

【0018】[0018]

【化7】 [Chemical 7]

【0019】[0019]

【化8】 Embedded image

【0020】当該化合物は、図1〜図5に示す合成法で
得られる化合物(12)、化合物(11)(XとYは一
緒になって炭素原子数2もしくは3のアルキレンジオキ
シ基を示すか、X及びYはともに炭素原子数1〜5のア
ルコキシ基を示す)、化合物(20)及び化合物(3
0)に対し、Li2CuCl4又はLiClなどの試薬と
反応させることにより得ることができる。図6にAが水
酸基であり、XとYが一緒になってオキソ基である本発
明化合物(34)の合成を示した。
The compound is a compound (12) or compound (11) (X and Y together represent an alkylenedioxy group having 2 or 3 carbon atoms) obtained by the synthetic method shown in FIGS. Or both X and Y represent an alkoxy group having 1 to 5 carbon atoms), compound (20) and compound (3
It can be obtained by reacting 0) with a reagent such as Li 2 CuCl 4 or LiCl. FIG. 6 shows the synthesis of the compound (34) of the present invention in which A is a hydroxyl group and X and Y together are an oxo group.

【0021】以下に、化合物(12)、化合物(11)
(XとYは一緒になって炭素原子数2もしくは3のアル
キレンジオキシ基を示すか、X及びYはともに炭素原子
数1〜5のアルコキシ基を示す。)、化合物(20)及
び化合物(30)の合成法について順次概説する。
The followings are compound (12) and compound (11).
(X and Y together represent an alkylenedioxy group having 2 or 3 carbon atoms, or both X and Y represent an alkoxy group having 1 to 5 carbon atoms), compound (20) and compound ( The synthetic method of 30) will be sequentially described.

【0022】1)化合物(12)及び化合物(11)
(XとYは一緒になって炭素原子数2もしくは3のアル
キレンジオキシ基を示すか、X及びYはともに炭素原子
数1〜5のアルコキシ基を示す。)の合成(図1、図
2) 化合物(1)にジイソプロピルエチルアミンなどの塩基
存在下、メトキシメチルクロリドを反応させて3位及び
12位の水酸基を保護した誘導体(2)に導き、次いで
化合物(2)にグリニヤ試薬を作用させて、低極性異性
体の20位アルコール体(3)及び高極性異性体の
(4)を得る。引続き、化合物(3)と化合物(4)の
混合物をイソプロパノールなどの低級アルコール中、濃
塩酸などの酸を作用させて20,22−(E)−オレフ
ィン体(5)を主生成物として得る。更に化合物(5)
をオッペナウアー酸化により3位ケトン体(6)に導
き、次いでパラトルエンスルホン酸などの酸触媒の存在
下、メタノールまたはエチレングリコールなどのアルコ
ールを反応させて3位ケトンの保護体(7)を得る。引
続き、化合物(7)にバナジウム触媒の存在下、及び炭
酸水素ナトリウムなどの塩基の存在下または非存在下、
tert−ブチルハイドロパーオキシドを作用させて、2
0,22−β−エポキシ体(8):高極性異性体及び2
0,22−α−エポキシ体(9):低極性異性体を約1
6:1〜5:1の生成比で得る。次いで、化合物(8)
にアルミニウムtert−ブトキシド、リチウムジイソプロ
ピルアミドまたはブロモマグネシウムジイソプロピルア
ミドなどの塩基を反応させてアリルアルコール体(1
0)に導き、更に炭酸水素ナトリウムなどの塩基の存在
下、メタクロロ過安息香酸を反応させてエポキシアルコ
ール体(11)を得ることができる。更に化合物(1
1)を酢酸などの酸で処理することにより3−ケトエポ
キシアルコール体(12)を得ることができる。また、
化合物(10)においてX及びYが一緒になって炭素原
子数2もしくは3のアルキレンジオキシ基の化合物の場
合、酢酸などの酸で処理して3−ケトン体(13)を
得、引き続き(13)に対してメタノールなどのアルコ
ールをパラトルエンスルホン酸などの酸触媒の存在下反
応させることにより、X及びYがともに炭素原子数1〜
5のアルコキシ基を示す化合物(10)を得ることがで
きる。なお、アリルアルコール体(10)は別法、即ち
化合物(8)にピリジンなどの有機塩基の存在下、無水
酢酸を反応させて12β−アセトキシ−20,22−β
−エポキシ体(14)に導き、更に有機溶媒中で塩化水
素などの酸を作用させて12β−アセトキシアリルアル
コール体(15)及び22α−アセトキシ体(16)の
混合物とした後、炭酸カリウムなどの塩基を用いてアセ
テートを加水分解する方法でも得ることができる。
1) Compound (12) and Compound (11)
(X and Y together represent an alkylenedioxy group having 2 or 3 carbon atoms, or both X and Y represent an alkoxy group having 1 to 5 carbon atoms.) (FIGS. 1 and 2) ) The compound (1) is reacted with methoxymethyl chloride in the presence of a base such as diisopropylethylamine to give a derivative (2) in which the hydroxyl groups at the 3- and 12-positions are protected, and then the compound (2) is reacted with a Grignard reagent. The low-polar isomer 20-position alcohol (3) and the high-polar isomer (4) are obtained. Subsequently, the mixture of the compound (3) and the compound (4) is treated with an acid such as concentrated hydrochloric acid in a lower alcohol such as isopropanol to obtain a 20,22- (E) -olefin compound (5) as a main product. Further compound (5)
To the 3-position ketone body (6) by Oppenauer oxidation, and then reacted with alcohol such as methanol or ethylene glycol in the presence of an acid catalyst such as paratoluenesulfonic acid to obtain a 3-position ketone protected body (7). Subsequently, the compound (7) in the presence of a vanadium catalyst, and in the presence or absence of a base such as sodium hydrogencarbonate,
By reacting tert-butyl hydroperoxide, 2
0,22-β-epoxy compound (8): highly polar isomer and 2
0,22-α-epoxy compound (9): low polar isomer of about 1
Obtained at a production ratio of 6: 1 to 5: 1. Then, compound (8)
The reaction with a base such as aluminum tert-butoxide, lithium diisopropylamide or bromomagnesium diisopropylamide to give an allyl alcohol derivative (1
0) and further reacted with metachloroperbenzoic acid in the presence of a base such as sodium hydrogen carbonate to obtain an epoxy alcohol compound (11). Furthermore, the compound (1
The 3-ketoepoxy alcohol compound (12) can be obtained by treating 1) with an acid such as acetic acid. Also,
In the compound (10), when X and Y are taken together to form a compound having an alkylenedioxy group having 2 or 3 carbon atoms, the compound is treated with an acid such as acetic acid to obtain a 3-ketone body (13), followed by (13 ) To an alcohol such as methanol in the presence of an acid catalyst such as p-toluenesulfonic acid, whereby both X and Y have 1 to 1 carbon atoms.
A compound (10) having an alkoxy group of 5 can be obtained. The allyl alcohol compound (10) is obtained by another method, that is, by reacting the compound (8) with acetic anhydride in the presence of an organic base such as pyridine, 12β-acetoxy-20,22-β.
-Leading to the epoxy compound (14) and further acting an acid such as hydrogen chloride in an organic solvent to give a mixture of 12β-acetoxyallyl alcohol compound (15) and 22α-acetoxy compound (16), and then adding potassium carbonate or the like. It can also be obtained by a method of hydrolyzing acetate using a base.

【0023】2)化合物(20)の合成(図3) 図1に示した製法により得た3β,12β−ジヒドロキ
シ−20,22−(E)−オレフィン体(5)にバナジ
ウム触媒の存在下、同時に炭酸水素ナトリウムなどの塩
基が存在または非存在の条件で、tert−ブチルハイドロ
パーオキシドを作用させて、主生成物の20,22−β
−エポキシ体(17)及び副生成物の20,22−α−
エポキシ体(18)を約10:1の生成比で得る。次い
で、化合物(17)にアルミニウムtert−ブトキシド、
リチウムジイソプロピルアミド、ブロモマグネシウムジ
イソプロピルアミドなどの塩基を反応させてアリルアル
コール体(19)に導き、更に炭酸水素ナトリウムなど
の塩基の存在下または非存在下、メタクロロ過安息香酸
を反応させて3β,12β−ジヒドロキシエポキシアル
コール体(20)を得ることができる。
2) Synthesis of compound (20) (FIG. 3) 3β, 12β-dihydroxy-20,22- (E) -olefin (5) obtained by the production method shown in FIG. 1 was prepared in the presence of a vanadium catalyst. At the same time, in the presence or absence of a base such as sodium hydrogen carbonate, tert-butyl hydroperoxide is allowed to act to give 20,22-β of the main product.
-Epoxy compound (17) and by-product 20,22-α-
The epoxy body (18) is obtained with a production ratio of about 10: 1. Then, to the compound (17), aluminum tert-butoxide,
React with a base such as lithium diisopropylamide or bromomagnesium diisopropylamide to lead to an allyl alcohol derivative (19), and further react with metachloroperbenzoic acid in the presence or absence of a base such as sodium hydrogencarbonate to give 3β, 12β. A dihydroxyepoxy alcohol body (20) can be obtained.

【0024】なお、アリルアルコール体(19)は図2
で示した別法に準拠し、3β,12β−ジアセトキシ体
(21及び22)及び3β,22α−ジアセトキシ体
(23)を経由する方法でも得ることができる。
The allyl alcohol compound (19) is shown in FIG.
It can also be obtained by a method involving the 3β, 12β-diacetoxy form (21 and 22) and the 3β, 22α-diacetoxy form (23), which is based on the alternative method shown in (3).

【0025】3)化合物(30)の合成(図4、図5) 化合物(5)を4−ニトロ安息香酸などの芳香族カルボ
ン酸を用いた光延反応により3位α−エステル体(2
4)に導き、次いで炭酸カリウムなどの塩基を用いて加
水分解し、3位α−ヒドロキシ体(25)を得る。引続
き、化合物(25)にバナジウム触媒の存在下、同時に
炭酸水素ナトリウムなどの塩基の存在または非存在の条
件で、tert−ブチルハイドロパーオキシドを作用させ
て、20,22−β−エポキシ体(26)、20,22−
α−エポキシ体(27)及び12位と22位での閉環体
(28)を約14:1:3〜20:1:1の生成比で得
る。次いで、化合物(26)にピリジンなどの有機塩基
の存在下、無水酢酸を反応させて3α,12β−ジアセ
トキシ−20,22−β−エポキシ体(31)に導き、
更に有機溶媒中で塩化水素などの酸を作用させて3α,
12β−ジアセトキシアリルアルコール体(32)及び
3α,22α−ジアセトキシ体(33)の混合物とした
後、炭酸カリウムなどの塩基を用いてアセテートを加水
分解してアリルアルコール体(29)を得る。更にアリ
ルアルコール体(29)に炭酸水素ナトリウムなどの塩
基の存在又は非存在の条件で、メタクロロ過安息香酸を
反応させて3α−ヒドロキシエポキシアルコール体(3
0)を得ることができる。なお、アリルアルコール体
(29)は別法、即ち化合物(26)にアルミニウムte
rt−ブトキシド、リチウムジイソプロピルアミド、ブロ
モマグネシウムジイソプロピルアミドなどの塩基を反応
させる方法でも得ることができる。
3) Synthesis of compound (30) (FIGS. 4 and 5) The compound (5) was subjected to Mitsunobu reaction with an aromatic carboxylic acid such as 4-nitrobenzoic acid to form a 3-position α-ester (2).
This is led to 4) and then hydrolyzed with a base such as potassium carbonate to obtain the 3-position α-hydroxy compound (25). Subsequently, the compound (25) was allowed to act with tert-butyl hydroperoxide in the presence of a vanadium catalyst and simultaneously with the presence or absence of a base such as sodium hydrogencarbonate to give a 20,22-β-epoxy compound (26 ), 20, 22-
The α-epoxy compound (27) and the ring-closed compound (28) at the 12- and 22-positions are obtained at a production ratio of about 14: 1: 3 to 20: 1: 1. Then, the compound (26) is reacted with acetic anhydride in the presence of an organic base such as pyridine to obtain a 3α, 12β-diacetoxy-20,22-β-epoxy compound (31),
Furthermore, by reacting an acid such as hydrogen chloride in an organic solvent, 3α,
After forming a mixture of the 12β-diacetoxyallyl alcohol compound (32) and the 3α, 22α-diacetoxy compound (33), the acetate is hydrolyzed with a base such as potassium carbonate to obtain an allyl alcohol compound (29). Further, the allyl alcohol compound (29) is reacted with metachloroperbenzoic acid under the presence or absence of a base such as sodium hydrogen carbonate to give a 3α-hydroxyepoxy alcohol compound (3
0) can be obtained. In addition, the allyl alcohol compound (29) is prepared by another method, that is, the compound (26) is replaced by aluminum te.
It can also be obtained by a method of reacting a base such as rt-butoxide, lithium diisopropylamide or bromomagnesium diisopropylamide.

【0026】次に、本発明の式(I)で示される化合物
のうち、Aが容易に加水分解されて水酸基になる基を有
する化合物の製法を概説する。これらの化合物は図1〜
5に合成法を示した化合物(11)、(12)、(2
0)及び(30)を原料にして製造することができる。
Next, of the compounds represented by the formula (I) of the present invention, a method for producing a compound having a group in which A is easily hydrolyzed to form a hydroxyl group will be outlined. These compounds are shown in Figure 1
Compounds (11), (12), and (2) whose synthetic methods are shown in FIG.
It can be manufactured using 0) and (30) as raw materials.

【0027】まず、容易に加水分解されて水酸基になる
基がアルカノイルオキシ基である化合物は、対応するア
ルカン酸、アルカン酸の酸ハロゲン化物、又はアルカン
酸の酸無水物を化合物(11)、(12)、(20)及
び(30)に対して一般的に用いられているエステル化
の条件にて反応させることにより得られる化合物を酢酸
エチルなどの有機溶媒中、塩化水素にて反応させること
により得ることができる。容易に加水分解されて水酸基
になる基が置換アルカノイルオキシ基である化合物は、
対応する置換アルカン酸、置換アルカン酸の酸ハロゲン
化物、または置換アルカン酸の酸無水物を化合物(1
1)、(12)、(20)及び(30)に対して一般的
に用いられているエステル化の条件にて反応させること
により得られる化合物を酢酸エチルなどの有機溶媒中、
塩化水素にて反応させることにより得ることができる。
置換アルカノイルオキシ基が3−スルホプロピオニルオ
キシ基である化合物は、化合物(11)、(12)、
(20)及び(30)に対してアクリル酸または塩化ア
クリロイルを一般的に用いられているエステル化の条件
にて反応させアクリル酸エステルとし、引き続きこれに
ピロ亜硫酸ナトリウムを反応させることにより得られる
化合物を酢酸エチルなどの有機溶媒中、塩化水素にて反
応させることにより得ることができる。
First, for a compound in which the group easily hydrolyzed to a hydroxyl group is an alkanoyloxy group, the corresponding alkanoic acid, alkanoic acid halide, or alkanoic acid anhydride is converted into compound (11), ( 12), (20) and (30) by reacting the compound obtained by the reaction under the commonly used esterification conditions with hydrogen chloride in an organic solvent such as ethyl acetate. Obtainable. A compound in which the group that is easily hydrolyzed to a hydroxyl group is a substituted alkanoyloxy group is
The corresponding substituted alkanoic acid, acid halide of the substituted alkanoic acid, or acid anhydride of the substituted alkanoic acid is converted to the compound (1
1), (12), (20) and (30) in an organic solvent such as ethyl acetate, the compound obtained by reacting under the conditions of esterification generally used,
It can be obtained by reacting with hydrogen chloride.
The compound whose substituted alkanoyloxy group is a 3-sulfopropionyloxy group is compound (11), (12),
A compound obtained by reacting (20) and (30) with acrylic acid or acryloyl chloride under commonly used esterification conditions to obtain an acrylic ester, and subsequently reacting this with sodium pyrosulfite. Can be obtained by reacting with hydrogen chloride in an organic solvent such as ethyl acetate.

【0028】容易に加水分解されて水酸基になる基がス
ルホオキシ基である化合物(硫酸モノエステル)は、化
合物(11)、(12)、(20)及び(30)に対し
て三酸化イオウ・ピリジン錯体を反応させることにより
得られる化合物を酢酸エチルなどの有機溶媒中、塩化水
素にて反応させることにより得ることができる。
The compound (sulfuric acid monoester) in which the group which is easily hydrolyzed to form a hydroxyl group is a sulfoxy group is a compound of sulfur trioxide / pyridine with respect to compounds (11), (12), (20) and (30). It can be obtained by reacting the compound obtained by reacting the complex with hydrogen chloride in an organic solvent such as ethyl acetate.

【0029】容易に加水分解されて水酸基になる基がホ
スホノオキシ基である化合物(りん酸モノエステル)
は、化合物(11)、(12)、(20)及び(30)
に対して一般的に用いられているりん酸エステル化の条
件にて反応を行い、保護されたりん酸トリエステルを
得、引き続き脱保護することにより得られる化合物を酢
酸エチルなどの有機溶媒中、塩化水素にて反応させるこ
とにより得ることができる。または、一般的に用いられ
ている亜りん酸エステル化の条件にて反応を行い、保護
された亜りん酸トリエステルとし、引き続きこれを常法
により酸化して保護されたりん酸トリエステルに変換
後、脱保護することによって得られる化合物を酢酸エチ
ルなどの有機溶媒中、塩化水素にて反応させることによ
っても得ることができる。
A compound in which the group easily hydrolyzed to form a hydroxyl group is a phosphonooxy group (phosphoric acid monoester)
Are compounds (11), (12), (20) and (30)
The reaction is carried out under the conditions of phosphoric acid esterification generally used for obtaining a protected phosphoric acid triester, followed by deprotection of the compound obtained in an organic solvent such as ethyl acetate, It can be obtained by reacting with hydrogen chloride. Alternatively, the reaction may be carried out under the generally used phosphite esterification conditions to obtain a protected phosphite triester, which is then oxidized by a conventional method to be converted to the protected phosphite triester. After that, the compound obtained by deprotection can also be obtained by reacting with hydrogen chloride in an organic solvent such as ethyl acetate.

【0030】本発明化合物のうち塩形成が可能な化合物
については一般的に用いられている処理により対応する
塩を得ることができる。
Among the compounds of the present invention, the compound capable of forming a salt can be obtained by the treatment generally used to obtain the corresponding salt.

【0031】本発明の式(I)で示される化合物のう
ち、AがN,N−ジエチルグリシルオキシ基であり、X
とYは一緒になってオキソ基である塩酸塩(36)の合
成法を図7に示す。Yが水素原子で、A及びXがともに
N,N−ジメチルグリシルオキシ基及びN,N−ジエチル
グリシルオキシ基である2塩酸塩(39)及び(40)
の合成法を図8に示す。AがN,N−ジメチルグリシル
オキシ基であり、Yが水酸基でXが水素原子である塩酸
塩(43)及びAとYがともにN,N−ジメチルグリシ
ルオキシ基であり、Xが水素原子である2塩酸塩(4
4)の合成法を図9に示す。
Among the compounds represented by the formula (I) of the present invention, A is an N, N-diethylglycyloxy group, and X
FIG. 7 shows a method for synthesizing a hydrochloride (36) in which Y and Y are together an oxo group. Dihydrochloride (39) and (40) wherein Y is a hydrogen atom and A and X are both N, N-dimethylglycyloxy group and N, N-diethylglycyloxy group.
FIG. 8 shows the synthetic method of A is a N, N-dimethylglycyloxy group, Y is a hydroxyl group and X is a hydrogen atom (43) and both A and Y are N, N-dimethylglycyloxy groups and X is hydrogen. Atomic dihydrochloride (4
The synthetic method of 4) is shown in FIG.

【0032】[0032]

【化9】 Embedded image

【0033】[0033]

【化10】 Embedded image

【0034】[0034]

【化11】 Embedded image

【0035】本発明のステロイド化合物又はその医薬上
許容される塩を医薬品として用いる場合、これを医薬組
成物に通常使用される担体(例えばタルク、アラビアゴ
ム、ラクトース、ステアリン酸マグネシウム、トウモロ
コシデンプン等)と混合し、経口または非経口投与の製
剤とする。その投与剤形としては錠剤、顆粒剤、散剤、
カプセル剤、シロップ剤、懸濁剤、注射剤が挙げられ
る。その投与量は、成人を治療する場合で1〜500m
gであり、これを1日2〜3回に分けて投与する。この
投与量は、患者の年齢、体重および症状によって適宜増
減することができる。
When the steroid compound of the present invention or a pharmaceutically acceptable salt thereof is used as a drug, it is a carrier usually used in pharmaceutical compositions (eg, talc, gum arabic, lactose, magnesium stearate, corn starch, etc.). It is mixed with to prepare a preparation for oral or parenteral administration. The dosage forms include tablets, granules, powders,
Capsules, syrups, suspensions, injections can be mentioned. The dose is 1 to 500 m when treating an adult
g, which is administered in 2 to 3 divided doses per day. This dose can be appropriately increased or decreased depending on the age, weight and condition of the patient.

【0036】[0036]

【発明の効果】本発明により、資源確保などに問題があ
る既知の海産物由来の化合物Cに代わり、17位側鎖構
造がより簡素化(不斉炭素の減少)された新規ステロイ
ド誘導体が立体選択的かつ効率のよい有機合成的手法に
より提供された。本発明の新規ステロイド誘導体は、化
合物Cに匹敵する腫瘍細胞に対する増殖阻害作用を有
し、有機合成的手法により容易に提供できることから、
抗腫瘍作用を有する医薬として有用である。
INDUSTRIAL APPLICABILITY According to the present invention, stereoselection of a novel steroid derivative in which the side chain structure at the 17-position is further simplified (the number of asymmetric carbons is reduced) is replaced with the known seafood-derived compound C, which has a problem in securing resources. It was provided by a synthetic organic method which is efficient and efficient. INDUSTRIAL APPLICABILITY The novel steroid derivative of the present invention has a growth inhibitory effect on tumor cells comparable to that of Compound C and can be easily provided by an organic synthetic method.
It is useful as a drug having an antitumor effect.

【0037】[0037]

【実施例】以下、実施例を挙げて本発明をさらに詳細に
説明する。なお、実施例に記載する化合物番号は図1〜
9に示した化合物番号に対応している。実施例に記載す
る化合物は、式(I)に示す本発明化合物のうちRがイ
ソブチルである化合物である。また、図1及び図2に示
した化合物のX及びYが一緒になってエチレンジオキシ
基である化合物について実施例に記載する。図2に示し
た化合物(10)及び(11)のX及びYがともにメト
キシ基である化合物をそれぞれ化合物(10a)及び
(11a)とし、実施例に記載する。
EXAMPLES The present invention will be described in more detail with reference to examples. In addition, the compound numbers described in Examples are shown in FIG.
It corresponds to the compound number shown in 9. The compounds described in the examples are compounds of the present invention represented by formula (I) in which R is isobutyl. In addition, compounds in which X and Y of the compounds shown in FIGS. 1 and 2 are together an ethylenedioxy group will be described in Examples. Compounds (10a) and (11) shown in FIG. 2 in which X and Y are both methoxy groups are referred to as compounds (10a) and (11a), and are described in the examples.

【0038】実施例 1)化合物(2)の合成 化合物(1)7.0gを塩化メチレン70mlに溶解
し、メトキシメチルクロリド5.05g及びジイソプロ
ピルエチルアミン8.10gを加え、7時間還流した。
放冷後、反応液に氷水を加えて酢酸エチルにて抽出し、
抽出液を水、飽和食塩水にて順次洗浄し、無水硫酸マグ
ネシウムにて乾燥した。溶媒を留去して得られた粗生成
物をシリカゲルカラムクロマトグラフィー[ヘキサン:
酢酸エチル=2:1(v/v)にて溶出]に付し、当該
化合物画分を得た。これをヘキサンより再結晶し、無色
プリズム晶(2)を6.7g(収率76%)得た。
Example 1) Synthesis of compound (2) 7.0 g of compound (1) was dissolved in 70 ml of methylene chloride, 5.05 g of methoxymethyl chloride and 8.10 g of diisopropylethylamine were added, and the mixture was refluxed for 7 hours.
After allowing to cool, ice water was added to the reaction solution and extracted with ethyl acetate,
The extract was washed successively with water and saturated brine, and dried over anhydrous magnesium sulfate. The crude product obtained by distilling off the solvent was subjected to silica gel column chromatography [hexane:
Elution with ethyl acetate = 2: 1 (v / v)] was performed to obtain the compound fraction. This was recrystallized from hexane to obtain 6.7 g (yield 76%) of colorless prism crystals (2).

【0039】mp:94〜95℃ Anal.Calcd for C25425:C,71.05;
H,10.02 Found:C,71.25;H,10.10 IR(KBr)cm-1:1701,1150,10421 H−NMR(CDCl3)δ:0.74(3H,s),0.82(3H,s),
2.19(3H,s),2.68(1H,t,J=8Hz),3.34(3H,s),3.36(3H,s),
3.34〜3.43(1H,m),3.43〜3.58(1H,m),4.63〜4.74(4H,m) FABMS(+KI) m/z:461(MK+)。
Mp: 94-95 ° C. Anal.Calcd for C 25 H 42 O 5 : C, 71.05;
H, 10.02 Found: C, 71.25; H, 10.10 IR (KBr) cm -1 : 1701,1150,1042 1 H-NMR (CDCl 3 ) δ: 0.74 (3H, s), 0.82 (3H, s),
2.19 (3H, s), 2.68 (1H, t, J = 8Hz), 3.34 (3H, s), 3.36 (3H, s),
3.34 to 3.43 (1H, m), 3.43 to 3.58 (1H, m), 4.63 to 4.74 (4H, m) FABMS (+ KI) m / z: 461 (MK + ).

【0040】2)化合物(3)及び化合物(4)の合成 アルゴン雰囲気下、マグネシウム2.01gに臭化イソ
アミル10.72gのジエチルエーテル100ml溶液
を室温にて滴下し、30分撹拌した。引続き、これを3
℃に冷却した後、化合物(2)10.0gのベンゼン1
00ml溶液を5℃以下にて滴下し、更に3℃にて3時
間撹拌した。反応液を塩化アンモニウム水溶液に注ぎ、
酢酸エチルにて抽出した。抽出液を飽和食塩水にて洗浄
し、無水硫酸マグネシウムにて乾燥後、溶媒を留去して
無色油状物を得た。これをシリカゲルカラムクロマトグ
ラフィー[ヘキサン:酢酸エチル=3:1(v/v)に
て溶出]にて精製し、先に溶出する画分から無色油状物
(3)を9.45g(収率81%)及び後から溶出する
画分から無色油状物(4)を1.57g(収率13%)
得た。
2) Synthesis of Compound (3) and Compound (4) Under argon atmosphere, a solution of 10.72 g of isoamyl bromide in 100 ml of diethyl ether was added dropwise to 2.01 g of magnesium at room temperature, and the mixture was stirred for 30 minutes. Continue to 3
After cooling to ℃, compound (2) 10.0 g benzene 1
The 00 ml solution was added dropwise at 5 ° C or lower, and the mixture was further stirred at 3 ° C for 3 hours. Pour the reaction solution into an aqueous solution of ammonium chloride,
Extracted with ethyl acetate. The extract was washed with saturated brine and dried over anhydrous magnesium sulfate, and the solvent was evaporated to give a colorless oil. This was purified by silica gel column chromatography [eluting with hexane: ethyl acetate = 3: 1 (v / v)], and 9.45 g (yield 81%) of colorless oil (3) from the fraction eluted earlier. ) And 1.57 g (13% yield) of colorless oily substance (4) from the fractions eluted later.
Obtained.

【0041】化合物(3) IR(neat)cm-1:3430,1152,10501 H−NMR(CDCl3)δ:0.83(3H,s),0.85(3H,s),
0.87(3H,d,J=5Hz),0.88(3H,d,J=5Hz),1.18(3H,s),3.31
〜3.59(2H,m),3.35(3H,s),3.41(3H,s),4.67(2H,s),4.70
(1H,d,J=6Hz),4.84(1H,d,J=6Hz),5.15(1H,brs) FABMS(+KI) m/z:533(MK+)。
Compound (3) IR (neat) cm -1 : 3430,1152,1050 1 H-NMR (CDCl 3 ) δ: 0.83 (3H, s), 0.85 (3H, s),
0.87 (3H, d, J = 5Hz), 0.88 (3H, d, J = 5Hz), 1.18 (3H, s), 3.31
~ 3.59 (2H, m), 3.35 (3H, s), 3.41 (3H, s), 4.67 (2H, s), 4.70
(1H, d, J = 6Hz), 4.84 (1H, d, J = 6Hz), 5.15 (1H, brs) FABMS (+ KI) m / z: 533 (MK + ).

【0042】化合物(4) IR(neat)cm-1:3431,1152,10501 H−NMR(CDCl3)δ:0.82(3H,s),0.85(3H,s),
0.87(3H,d,J=6Hz),0.89(3H,d,J=6Hz),1.03(3H,s),3.33
〜3.43(1H,m),3.36(3H,s),3.40(3H,s),3.42〜3.58(1H,
m),4.67(2H,s),4.70(1H,d,J=6Hz),4.83(1H,d,J=6Hz) FABMS(+KI) m/z:533(MK+)。
Compound (4) IR (neat) cm -1 : 3431,1152,1050 1 H-NMR (CDCl 3 ) δ: 0.82 (3H, s), 0.85 (3H, s),
0.87 (3H, d, J = 6Hz), 0.89 (3H, d, J = 6Hz), 1.03 (3H, s), 3.33
~ 3.43 (1H, m), 3.36 (3H, s), 3.40 (3H, s), 3.42 ~ 3.58 (1H,
m), 4.67 (2H, s), 4.70 (1H, d, J = 6Hz), 4.83 (1H, d, J = 6Hz) FABMS (+ KI) m / z: 533 (MK + ).

【0043】3)化合物(5)の合成 化合物(3)9.45gと化合物(4)1.57gの混合
物をイソプロパノール330mlに溶解し、濃塩酸1.
98mlを加えて9時間還流した。反応液を冷却後溶媒
を留去し、得られた残渣をクロロホルムに溶解して飽和
食塩水にて洗浄した。この溶液を無水硫酸マグネシウム
にて乾燥後、溶媒を留去して粗生成物を得た。これをシ
リカゲルカラムクロマトグラフィー[クロロホルム:酢
酸エチル=10:1(v/v)にて溶出]に付し、当該
化合物画分を酢酸エチルにて再結晶し、無色微細針状晶
(5)を5.87g(収率68%)得た。
3) Synthesis of compound (5) A mixture of 9.45 g of compound (3) and 1.57 g of compound (4) was dissolved in 330 ml of isopropanol, and concentrated hydrochloric acid (1.
98 ml was added and the mixture was refluxed for 9 hours. After cooling the reaction solution, the solvent was evaporated, the obtained residue was dissolved in chloroform and washed with saturated saline. The solution was dried over anhydrous magnesium sulfate and the solvent was distilled off to obtain a crude product. This was subjected to silica gel column chromatography [eluting with chloroform: ethyl acetate = 10: 1 (v / v)], and the compound fraction was recrystallized with ethyl acetate to give colorless fine needle crystals (5). 5.87 g (yield 68%) was obtained.

【0044】mp:195〜198℃ Anal.Calcd for C26442:C,80.35;
H,11.41 Found:C,80.64;H,11.59 IR(KBr)cm-1:3460,2949,2925,2867,1466 1
H−NMR(CDCl3)δ:0.73(3H,s),0.8
1(3H,s),0.89(6H,d,J=5Hz),1.67(3H,s),1.90(2H,t,J=6H
z),2.29(1H,t,J=8Hz),3.50〜3.68(2H,m),5.51(1H,t,J=6
Hz) FABMS(+KI) m/z:427(MK+)。
Mp: 195-198 ° C. Anal.Calcd for C 26 H 44 O 2 : C, 80.35;
H, 11.41 Found: C, 80.64; H, 11.59 IR (KBr) cm -1 : 3460,2949,2925,2867,1466 1
1 H-NMR (CDCl 3 ) δ: 0.73 (3H, s), 0.8
1 (3H, s), 0.89 (6H, d, J = 5Hz), 1.67 (3H, s), 1.90 (2H, t, J = 6H
z), 2.29 (1H, t, J = 8Hz), 3.50-3.68 (2H, m), 5.51 (1H, t, J = 6
Hz) FABMS (+ KI) m / z: 427 (MK + ).

【0045】4)化合物(6)の合成 化合物(5)2.0gをトルエン62mlに溶解し、シ
クロヘキサノン16mlを加え、ディーンスタークトラ
ップをつけて10分間還流した。引続き、アルミニウム
イソプロポキシド1.58gを加えて1時間還流した。
反応液に希塩酸を加えて酢酸エチルにて抽出し、飽和食
塩水にて洗浄後、無水硫酸マグネシウムにて乾燥した。
溶媒を留去して得られた粗生成物をシリカゲルカラムク
ロマトグラフィー[ヘキサン:酢酸エチル=6:1(v
/v)にて溶出]にて精製し、無色微細針状晶(6)を
1.45g(収率73%)得た。
4) Synthesis of compound (6) 2.0 g of compound (5) was dissolved in 62 ml of toluene, 16 ml of cyclohexanone was added, and the mixture was refluxed for 10 minutes with a Dean Stark trap. Subsequently, 1.58 g of aluminum isopropoxide was added and the mixture was refluxed for 1 hour.
Dilute hydrochloric acid was added to the reaction solution, which was extracted with ethyl acetate, washed with saturated saline, and then dried over anhydrous magnesium sulfate.
The crude product obtained by distilling off the solvent was subjected to silica gel column chromatography [hexane: ethyl acetate = 6: 1 (v
/ V)]] to obtain 1.45 g (yield 73%) of colorless fine needle crystals (6).

【0046】mp:103〜105℃ Anal.Calcd for C26422:C,80.77;
H,10.95 Found:C,80.65;H,11.02 IR(KBr)cm-1:3555,3420,17191 H−NMR(CDCl3)δ:0.76(3H,s),0.86(3H,d,J
=5Hz),0.87(3H,d,J=5Hz),1.02(3H,s),1.67(3H,s),3.61
(1H,dd,J=10 and 5Hz),5.52(1H,dt,J=6 and 1Hz) FABMS(+KI) m/z:425(MK+)。
Mp: 103-105 ° C. Anal.Calcd for C 26 H 42 O 2 : C, 80.77;
H, 10.95 Found: C, 80.65; H, 11.02 IR (KBr) cm -1 : 3555,3420,1719 1 H-NMR (CDCl 3 ) δ: 0.76 (3H, s), 0.86 (3H, d, J
= 5Hz), 0.87 (3H, d, J = 5Hz), 1.02 (3H, s), 1.67 (3H, s), 3.61
(1H, dd, J = 10 and 5Hz), 5.52 (1H, dt, J = 6 and 1Hz) FABMS (+ KI) m / z: 425 (MK + ).

【0047】5)化合物(7)の合成 化合物(6)1.8gをベンゼン90mlに溶解し、エ
チレングリコール2.6ml及びパラトルエンスルホン
酸0.08gを加えてディーンスタークトラップをつけ
10分間還流した。反応液に酢酸エチルを加え、飽和炭
酸水素ナトリウム水溶液及び飽和食塩水にて順次洗浄
し、無水硫酸マグネシウムにて乾燥した。溶媒を留去し
て得られた粗生成物をシリカゲルカラムクロマトグラフ
ィー[ヘキサン:酢酸エチル=5:1(v/v)にて溶
出]にて精製し、無色粉末(7)を1.56g(収率7
8%)得た。
5) Synthesis of compound (7) 1.8 g of compound (6) was dissolved in 90 ml of benzene, 2.6 ml of ethylene glycol and 0.08 g of paratoluenesulfonic acid were added, and the mixture was refluxed for 10 minutes with a Dean Stark trap. . Ethyl acetate was added to the reaction solution, which was washed successively with saturated aqueous sodium hydrogen carbonate solution and saturated brine, and dried over anhydrous magnesium sulfate. The crude product obtained by distilling off the solvent was purified by silica gel column chromatography [eluting with hexane: ethyl acetate = 5: 1 (v / v)] to obtain 1.56 g of colorless powder (7) ( Yield 7
8%) was obtained.

【0048】mp:146〜147℃ Anal.Calcd for C28463:C,78.09;
H,10.77 Found:C,78.27;H,10.77 IR(KBr)cm-1:3459,2952,14671 H−NMR(CDCl3)δ:0.73(3H,s),0.82(3H,s),
0.89(6H,d,J=6Hz),1.67(3H,s),1.90(1H,t,J=6Hz),2.30
(1H,t,J=10Hz),3.59(1H,dd,J=10 and 5Hz),3.93(4H,s),
5.52(1H,t,J=6Hz) FABMS(+KI) m/z:469(MK+)。
Mp: 146-147 ° C. Anal.Calcd for C 28 H 46 O 3 : C, 78.09;
H, 10.77 Found: C, 78.27; H, 10.77 IR (KBr) cm −1 : 3459,2952,1467 1 H-NMR (CDCl 3 ) δ: 0.73 (3H, s), 0.82 (3H, s),
0.89 (6H, d, J = 6Hz), 1.67 (3H, s), 1.90 (1H, t, J = 6Hz), 2.30
(1H, t, J = 10Hz), 3.59 (1H, dd, J = 10 and 5Hz), 3.93 (4H, s),
5.52 (1H, t, J = 6Hz) FABMS (+ KI) m / z: 469 (MK + ).

【0049】6)化合物(8)及び化合物(9)の合成 化合物(7)1.2gを窒素雰囲気下、塩化メチレン3
0mlに溶解後、酸化バナジウムアセチルアセトネート
15mgを加え、室温にて10分間撹拌した。溶液を氷
冷後、tert−ブチルハイドロパーオキシド(3.3規定
塩化メチレン溶液)1.7mlを滴下し、室温まで昇
温して2時間撹拌した。反応液をジエチルエーテルにて
希釈し、フロリジルのショートカラムを通過させた後、
濃縮した。得られた粗生成物をシリカゲルフラッシュカ
ラムクロマトグラフィー[ヘキサン:酢酸エチル=3:
1(v/v)にて溶出]に付し、先に溶出する画分から
無色粉末(9)を54mg(収率4%)及び後から溶出
する画分から無色粉末(8)を860mg(収率68
%)得た。
6) Synthesis of Compound (8) and Compound (9) 1.2 g of Compound (7) was added to methylene chloride 3 in a nitrogen atmosphere.
After dissolving in 0 ml, 15 mg of vanadium oxide acetylacetonate was added, and the mixture was stirred at room temperature for 10 minutes. After ice-cooling the solution, 1.7 ml of tert-butyl hydroperoxide (3.3N methylene chloride solution) was added dropwise, the temperature was raised to room temperature, and the mixture was stirred for 2 hours. After diluting the reaction solution with diethyl ether and passing it through a short column of Florisil,
Concentrated. The obtained crude product was subjected to silica gel flash column chromatography [hexane: ethyl acetate = 3:
1 (v / v)], and 54 mg (yield 4%) of colorless powder (9) from the fraction eluted first and 860 mg (yield of colorless powder (8) from the fraction eluted later). 68
%)Obtained.

【0050】化合物(8) mp:130〜132℃ Anal.Calcd for C28464:C,75.29;
H,10.38 Found:C,75.25;H,10.50 IR(KBr)cm-1:3455,3338,2937,1105,1073,102
11 H−NMR(CDCl3)δ:0.70(3H,s),0.79(3H,s),
0.94(3H,d,J=7Hz),0.97(3H,d,J=7Hz),1.27(3H,s),3.23
(1H,dd,J=11 and 5Hz),3.34(1H,t,J=7Hz),3.92(4H,s) FABMS m/z:447(MH+)。
Compound (8) mp: 130-132 ° C. Anal.Calcd for C 28 H 46 O 4 : C, 75.29;
H, 10.38 Found: C, 75.25; H, 10.50 IR (KBr) cm -1 : 3455,3338,2937,1105,1073,102
1 1 H-NMR (CDCl 3 ) δ: 0.70 (3H, s), 0.79 (3H, s),
0.94 (3H, d, J = 7Hz), 0.97 (3H, d, J = 7Hz), 1.27 (3H, s), 3.23
(1H, dd, J = 11 and 5Hz), 3.34 (1H, t, J = 7Hz), 3.92 (4H, s) FABMS m / z: 447 (MH + ).

【0051】化合物(9) mp:105〜108℃ Anal.Calcd for C28464:C,75.29;
H,10.38 Found:C,75.48;H,10.48 IR(KBr)cm-1:3468,2948,2872,1469,10731 H−NMR(CDCl3)δ:0.82(3H,s),0.84(3H,s),
0.94(3H,d,J=5Hz),0.97(3H,d,J=5Hz),1.27(3H,s),2.76
(1H,t,J=6Hz),3.17(1H,dd,J=10 and 4Hz),3.92(4H,s),
4.42(1H,s) FABMS(+KI) m/z:485(MK+)。
Compound (9) mp: 105 to 108 ° C. Anal.Calcd for C 28 H 46 O 4 : C, 75.29;
H, 10.38 Found: C, 75.48; H, 10.48 IR (KBr) cm −1 : 3468,2948,2872,1469,1073 1 H-NMR (CDCl 3 ) δ: 0.82 (3H, s), 0.84 (3H, s),
0.94 (3H, d, J = 5Hz), 0.97 (3H, d, J = 5Hz), 1.27 (3H, s), 2.76
(1H, t, J = 6Hz), 3.17 (1H, dd, J = 10 and 4Hz), 3.92 (4H, s),
4.42 (1H, s) FABMS (+ KI) m / z: 485 (MK + ).

【0052】7)化合物(10)の合成 化合物(8)100mgをトルエン2mlに溶解後、ア
ルミニウム tert-ブトキシド60mgを加え、2時
間加熱還流した。反応液をジエチルエーテルで希釈し、
飽和硫酸マグネシウム水溶液300μlを加え室温で激
しく撹拌した後、過剰の無水硫酸マグネシウムを加え、
さらに10分間撹拌した。濾過後、濃縮して得られた粗
生成物をシリカゲルカラムクロマトグラフィー[ヘキサ
ン:酢酸エチル=5:1(v/v)にて溶出]にて精製
し、無色粉末(10)を59mg(収率59%)得た。
7) Synthesis of compound (10) After dissolving 100 mg of compound (8) in 2 ml of toluene, 60 mg of aluminum tert-butoxide was added and the mixture was heated under reflux for 2 hours. Dilute the reaction with diethyl ether,
After adding 300 μl of a saturated aqueous solution of magnesium sulfate and vigorously stirring at room temperature, excess anhydrous magnesium sulfate was added,
Stir for a further 10 minutes. The crude product obtained by concentration after filtration is purified by silica gel column chromatography [eluting with hexane: ethyl acetate = 5: 1 (v / v)] to give 59 mg of colorless powder (10) (yield 59%).

【0053】mp:222〜223℃ Anal.Calcd for C28464:C,75.29;
H,10.38 Found:C,75.50;H,10.52 IR(KBr)cm-1:3310,2950,2868,13581 H−NMR(CDCl3)δ:0.73(3H,s),0.82(3H,s),
0.91(3H,d,J=5Hz),0.92(3H,d,J=5Hz),3.47(1H,dd,J=10
and 4Hz),3.94(4H,s),4.25(1H,t,J=7Hz),4.93(1H,s),5.
09(1H,s) FABMS(+KI) m/z:485(MK+)。
Mp: 222-223 ° C. Anal.Calcd for C 28 H 46 O 4 : C, 75.29;
H, 10.38 Found: C, 75.50; H, 10.52 IR (KBr) cm -1 : 3310,2950,2868,1358 1 H-NMR (CDCl 3 ) δ: 0.73 (3H, s), 0.82 (3H, s) ,
0.91 (3H, d, J = 5Hz), 0.92 (3H, d, J = 5Hz), 3.47 (1H, dd, J = 10
and 4Hz), 3.94 (4H, s), 4.25 (1H, t, J = 7Hz), 4.93 (1H, s), 5.
09 (1H, s) FABMS (+ KI) m / z: 485 (MK + ).

【0054】8)化合物(11)の合成 化合物(10)0.28gを塩化メチレン6.9mlに溶
解し、氷水浴中で冷却して炭酸水素ナトリウム0.06
5g及びメタクロロ過安息香酸0.188gを加え、4
時間撹拌後さらに室温にて6時間撹拌した。反応液にチ
オ硫酸ナトリウム水溶液を加え、酢酸エチルにて抽出し
た。抽出液を飽和炭酸水素ナトリウム水溶液及び飽和食
塩水にて順次洗浄し、無水硫酸マグネシウムにて乾燥
後、溶媒を留去して粗生成物を得た。これをシリカゲル
カラムクロマトグラフィー[ヘキサン:酢酸エチル=
3:2(v/v)にて溶出]に付し、当該化合物画分
(0.27g)を酢酸エチル−ヘキサンにて再結晶し、
無色微細針状晶(11)を0.17g(収率58%)得
た。
8) Synthesis of compound (11) 0.28 g of compound (10) was dissolved in 6.9 ml of methylene chloride and cooled in an ice-water bath to obtain sodium hydrogencarbonate 0.06.
Add 5 g and 0.188 g of metachloroperbenzoic acid and add 4
After stirring for an hour, the mixture was further stirred at room temperature for 6 hours. Aqueous sodium thiosulfate solution was added to the reaction solution, and the mixture was extracted with ethyl acetate. The extract was washed successively with saturated aqueous sodium hydrogen carbonate solution and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated to give a crude product. This is subjected to silica gel column chromatography [hexane: ethyl acetate =
3: 2 (v / v)] and the compound fraction (0.27 g) was recrystallized from ethyl acetate-hexane,
0.17 g (yield 58%) of colorless fine needle crystals (11) were obtained.

【0055】mp:174〜176℃ Anal.Calcd for C28465:C,72.69;
H,10.02 Found:C,72.83;H,10.12 IR(KBr)cm-1:3368,2948,2870,10961 H−NMR(CDCl3)δ:0.68(3H,s),0.80(3H,s),
0.91(3H,d,J=6Hz),0.94(3H,d,J=6Hz),2.14(1H,t,J=8H
z),2.88(1H,d,J=4Hz),3.06(1H,d,J=4Hz),3.36(1H,dd,J=
10 and 5Hz),3.44(1H,dd,J=10 and 4Hz),3.93(4H,s),4.
14(1H,brs) LSIMS(+KI) m/z:501(MK+)。
Mp: 174-176 ° C. Anal.Calcd for C 28 H 46 O 5 : C, 72.69;
H, 10.02 Found: C, 72.83; H, 10.12 IR (KBr) cm -1 : 3368,2948,2870,1096 1 H-NMR (CDCl 3 ) δ: 0.68 (3H, s), 0.80 (3H, s) ,
0.91 (3H, d, J = 6Hz), 0.94 (3H, d, J = 6Hz), 2.14 (1H, t, J = 8H
z), 2.88 (1H, d, J = 4Hz), 3.06 (1H, d, J = 4Hz), 3.36 (1H, dd, J =
10 and 5Hz), 3.44 (1H, dd, J = 10 and 4Hz), 3.93 (4H, s), 4.
14 (1H, brs) LSIMS (+ KI) m / z: 501 (MK + ).

【0056】9)化合物(12)の合成 化合物(11)0.23gを80%(w/w)酢酸水溶
液10mlに溶解し、室温にて1時間撹拌した。反応液
に水を加え、酢酸エチルにて抽出して飽和炭酸水素ナト
リウム水溶液及び飽和食塩水にて順次洗浄後、無水硫酸
マグネシウムにて乾燥した。溶媒を留去して得られた粗
生成物をシリカゲルカラムクロマトグラフィー[ヘキサ
ン:酢酸エチル=1:1(v/v)にて溶出]にて精製
し、無色粉末(12)を0.13g(収率63%)得
た。
9) Synthesis of compound (12) 0.23 g of compound (11) was dissolved in 10 ml of 80% (w / w) acetic acid aqueous solution and stirred at room temperature for 1 hour. Water was added to the reaction solution, which was extracted with ethyl acetate, washed successively with saturated aqueous sodium hydrogen carbonate solution and saturated brine, and dried over anhydrous magnesium sulfate. The crude product obtained by distilling off the solvent was purified by silica gel column chromatography [eluting with hexane: ethyl acetate = 1: 1 (v / v)] to obtain 0.13 g of colorless powder (12) ( Yield 63%).

【0057】mp:188〜190℃ Anal.Calcd for C26424:C,74.60;
H,10.11 Found:C,74.73;H,10.26 IR(KBr)cm-1:3426,2943,2869,1708,10301 H−NMR(CDCl3)δ:0.72(3H,s),0.90(3H,d,J
=6Hz),0.95(3H,d,J=6Hz),1.00(3H,s),2.89(1H,d,J=4H
z),3.07(1H,d,J=4Hz),3.39(1H,dd,J=10 and 4Hz),3.45
(1H,dd,J=10 and 4Hz),4.21(1H,brs) LSIMS(+KI) m/z:457(MK+)。
Mp: 188-190 ° C. Anal.Calcd for C 26 H 42 O 4 : C, 74.60;
H, 10.11 Found: C, 74.73; H, 10.26 IR (KBr) cm −1 : 3426,2943,2869,1708,1030 1 H-NMR (CDCl 3 ) δ: 0.72 (3H, s), 0.90 (3H, d, J
= 6Hz), 0.95 (3H, d, J = 6Hz), 1.00 (3H, s), 2.89 (1H, d, J = 4H
z), 3.07 (1H, d, J = 4Hz), 3.39 (1H, dd, J = 10 and 4Hz), 3.45
(1H, dd, J = 10 and 4Hz), 4.21 (1H, brs) LSIMS (+ KI) m / z: 457 (MK + ).

【0058】以下、化合物(12)の別途合成法につい
て記載する。
A separate method for synthesizing the compound (12) will be described below.

【0059】10)化合物(13)の合成 化合物(10)0.466gを80%(w/w)酢酸水
溶液23mlに懸濁し、50〜70℃にて15分加熱し
て溶解させた。反応液を室温まで冷却し、酢酸エチルを
加えて水、5%水酸化ナトリウム水溶液及び飽和食塩水
にて順次洗浄し、無水硫酸マグネシウムにて乾燥した。
溶媒を減圧下留去し、無色粉末(13)を0.413g
(収率98.3%)を得た。
10) Synthesis of compound (13) 0.466 g of compound (10) was suspended in 23 ml of 80% (w / w) aqueous acetic acid solution and heated at 50 to 70 ° C. for 15 minutes to dissolve. The reaction mixture was cooled to room temperature, ethyl acetate was added, and the mixture was washed successively with water, 5% aqueous sodium hydroxide solution and saturated brine, and dried over anhydrous magnesium sulfate.
The solvent was evaporated under reduced pressure, and colorless powder (13) (0.413 g)
(Yield 98.3%) was obtained.

【0060】mp:205〜209℃ Anal.Calcd for C26423:C,77.56;
H,10.52 Found:C,77.64;H,10.56 IR(KBr)cm-1:3294,2953,2935,1714,10241 H−NMR(CDCl3)δ:0.77(3H,s),0.91(3H,d,J
=6Hz),0.92(3H,d,J=6Hz),1.03(3H,s),3.02(2H,s),3.52
(1H,dd,J=11 and 5Hz),4.27(1H,t,J=6Hz),4.94(1H,s),
5.12(1H,s) LSIMS(+KI) m/z:441(MK+)。
Mp: 205-209 ° C. Anal.Calcd for C 26 H 42 O 3 : C, 77.56;
H, 10.52 Found: C, 77.64; H, 10.56 IR (KBr) cm −1 : 3294,2953,2935,1714,1024 1 H-NMR (CDCl 3 ) δ: 0.77 (3H, s), 0.91 (3H, d, J
= 6Hz), 0.92 (3H, d, J = 6Hz), 1.03 (3H, s), 3.02 (2H, s), 3.52
(1H, dd, J = 11 and 5Hz), 4.27 (1H, t, J = 6Hz), 4.94 (1H, s),
5.12 (1H, s) LSIMS (+ KI) m / z: 441 (MK + ).

【0061】11)化合物(10a)の合成 化合物(13)0.413gをメタノール30mlに溶
解し、パラトルエンスルホン酸0.019gを加えて室
温にて15.5時間撹拌した。反応液に飽和炭酸水素ナ
トリウム水溶液を加え、酢酸エチルにて抽出し、飽和食
塩水にて洗浄後、無水硫酸マグネシウムにて乾燥した。
溶媒を減圧下留去し、無色粉末(10a)を0.460
g(収率100%)得た。
11) Synthesis of compound (10a) 0.413 g of compound (13) was dissolved in 30 ml of methanol, 0.019 g of paratoluenesulfonic acid was added, and the mixture was stirred at room temperature for 15.5 hours. A saturated aqueous sodium hydrogen carbonate solution was added to the reaction solution, extracted with ethyl acetate, washed with saturated saline, and then dried over anhydrous magnesium sulfate.
The solvent was distilled off under reduced pressure to give colorless powder (10a) 0.460.
g (yield 100%) was obtained.

【0062】mp:162〜166℃ IR(KBr)cm-1:3334,2952,1470,1444,1072,105
4,10201 H−NMR(CDCl3)δ:0.75(3H,s),0.83(3H,s),
0.93(3H,d,J=7Hz),0.94(3H,d,J=7Hz),2.35(1H,t,J=10H
z),3.16(3H,s),3.20(3H,s),3.49(1H,dd,J=11 and 5Hz),
4.27(1H,t,J=7Hz),4.94(1H,s),5.12(1H,s) LSIMS(+KI) m/z:487(MK+)。
Mp: 162 to 166 ° C. IR (KBr) cm −1 : 3334,2952,1470,1444,1072,105
4,1020 1 H-NMR (CDCl 3 ) δ: 0.75 (3H, s), 0.83 (3H, s),
0.93 (3H, d, J = 7Hz), 0.94 (3H, d, J = 7Hz), 2.35 (1H, t, J = 10H
z), 3.16 (3H, s), 3.20 (3H, s), 3.49 (1H, dd, J = 11 and 5Hz),
4.27 (1H, t, J = 7Hz), 4.94 (1H, s), 5.12 (1H, s) LSIMS (+ KI) m / z: 487 (MK + ).

【0063】12)化合物(11a)の合成 化合物(10a)0.442gを塩化メチレン20ml
に溶解し、炭酸水素ナトリウム0.279g及びメタク
ロロ過安息香酸0.325gを加え、室温にて6時間撹
拌した。反応液に飽和チオ硫酸ナトリウム水溶液を加
え、酢酸エチルにて抽出し、飽和炭酸水素ナトリウム水
溶液及び飽和食塩水にて順次洗浄後、無水硫酸マグネシ
ウムにて乾燥した。溶媒を減圧留去して得られた粗生成
物をシリカゲルカラムクロマトグラフィー[ヘキサン:
酢酸エチル=2:1(V/V)にて溶出]に付し、先に
溶出する画分から無色粉末(11a)を0.360g
(収率78.6%)、後から溶出する画分から無色粉末
(12)を0.021g(収率5.1%)得た。
12) Synthesis of compound (11a) 0.442 g of compound (10a) was added to 20 ml of methylene chloride.
The resulting mixture was dissolved in water, 0.279 g of sodium hydrogen carbonate and 0.325 g of metachloroperbenzoic acid were added, and the mixture was stirred at room temperature for 6 hours. A saturated aqueous solution of sodium thiosulfate was added to the reaction solution, extracted with ethyl acetate, washed successively with a saturated aqueous solution of sodium hydrogen carbonate and saturated saline, and then dried over anhydrous magnesium sulfate. The crude product obtained by distilling off the solvent under reduced pressure was subjected to silica gel column chromatography [hexane:
Elution with ethyl acetate = 2: 1 (V / V)], and 0.360 g of colorless powder (11a) from the fraction eluted first.
(Yield 78.6%), and 0.021 g (Yield 5.1%) of colorless powder (12) was obtained from the fraction eluted later.

【0064】mp:149〜152℃ IR(KBr)cm-1:3372,2956,1470,1444,1072,105
2,10241 H−NMR(CDCl3)δ:0.68(3H,s),0.78(3H,s),
0.91(3H,d,J=7Hz),0.95(3H,d,J=7Hz),2.88(1H,d,J=4H
z),3.06(1H,d,J=4Hz),3.13(3H,s),3.18(3H,s),3.31〜3.
50(2H,m),4.16(1H,brs) LSIMS(+KI) m/z:503(MK+)。
Mp: 149-152 ° C. IR (KBr) cm −1 : 3372,2956,1470,1444,1072,105
2,1024 1 H-NMR (CDCl 3 ) δ: 0.68 (3H, s), 0.78 (3H, s),
0.91 (3H, d, J = 7Hz), 0.95 (3H, d, J = 7Hz), 2.88 (1H, d, J = 4H
z), 3.06 (1H, d, J = 4Hz), 3.13 (3H, s), 3.18 (3H, s), 3.31 ~ 3.
50 (2H, m), 4.16 (1H, brs) LSIMS (+ KI) m / z: 503 (MK + ).

【0065】13)化合物(12)の合成 化合物(11a)0.347gを80%(w/w)酢酸
水溶液9.3mlに溶解し、室温にて5分撹拌した。反
応液に酢酸エチルを加え、飽和炭酸水素ナトリウム水溶
液及び飽和食塩水にて順次洗浄後、無水硫酸ナトリウム
にて乾燥した。溶媒を減圧留去して得られた粗生成物を
シリカゲルカラムクロマトグラフィー[ヘキサン:酢酸
エチル=1:1(V/V)にて溶出]に付し、無色粉末
(12)を0.270g(収率86.5%)得た。
13) Synthesis of compound (12) 0.347 g of compound (11a) was dissolved in 9.3 ml of 80% (w / w) aqueous acetic acid solution, and the mixture was stirred at room temperature for 5 minutes. Ethyl acetate was added to the reaction solution, which was washed successively with saturated aqueous sodium hydrogen carbonate solution and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure and the obtained crude product was subjected to silica gel column chromatography [eluting with hexane: ethyl acetate = 1: 1 (V / V)] to obtain 0.270 g of colorless powder (12) ( Yield 86.5%) was obtained.

【0066】以下、化合物(10)の別途合成法を記載
する。 14)化合物(14)の合成 化合物(8)3.51gをピリジン40mlに溶解し、
無水酢酸3.7ml及び4−ジメチルアミノピリジン0.
48gを加えて室温にて3時間撹拌した。反応液に酢酸
エチルを加え、希塩酸、飽和炭酸水素ナトリウム水溶
液、飽和食塩水にて順次洗浄し、無水硫酸マグネシウム
にて乾燥した。溶媒を留去して得られた粗生成物をシリ
カゲルカラムクロマトグラフィー[ヘキサン:酢酸エチ
ル=5:1(v/v)にて溶出]にて精製し、無色粉末
(14)を3.61g(収率94%)得た。
Hereinafter, another method for synthesizing the compound (10) will be described. 14) Synthesis of compound (14) 3.51 g of compound (8) is dissolved in 40 ml of pyridine,
3.7 ml of acetic anhydride and 0.4 of 4-dimethylaminopyridine.
48 g was added and the mixture was stirred at room temperature for 3 hours. Ethyl acetate was added to the reaction solution, which was washed successively with diluted hydrochloric acid, saturated aqueous sodium hydrogen carbonate solution and saturated brine, and dried over anhydrous magnesium sulfate. The crude product obtained by distilling off the solvent was purified by silica gel column chromatography [eluting with hexane: ethyl acetate = 5: 1 (v / v)] to give 3.61 g of colorless powder (14) ( Yield 94%).

【0067】mp:169〜171℃ Anal.Calcd for C30485:C,73.73;
H,9.90 Found:C,73.83;H,9.96 IR(KBr)cm-1:2957,2930,1731,12451 H−NMR(DMSO−d6)δ:0.75(3H,s),0.79(3
H,s),0.90(6H,d,J=6Hz),1.15(3H,s),2.00(3H,s),2.44(1
H,dd,J=9 and 3Hz),3.82(4H,s),4.53(1H,dd,J=11 and 5
Hz) LSIMS m/z:489(MH+)。
Mp: 169-171 ° C. Anal.Calcd for C 30 H 48 O 5 : C, 73.73;
H, 9.90 Found: C, 73.83; H, 9.96 IR (KBr) cm -1 : 2957,2930,1731,1245 1 H-NMR (DMSO-d 6 ) δ: 0.75 (3H, s), 0.79 (3
H, s), 0.90 (6H, d, J = 6Hz), 1.15 (3H, s), 2.00 (3H, s), 2.44 (1
H, dd, J = 9 and 3Hz), 3.82 (4H, s), 4.53 (1H, dd, J = 11 and 5
Hz) LSIMS m / z: 489 (MH + ).

【0068】15)化合物(15)及び化合物(16)
の合成 化合物(14)0.41gに0.01規定塩化水素酢酸エ
チル溶液16mlを加え、室温にて1時間撹拌した。反
応液に飽和炭酸水素ナトリウム水溶液を加えて酢酸エチ
ルにて抽出し、飽和食塩水にて洗浄後、無水硫酸マグネ
シウムにて乾燥した。溶媒を留去して得られた粗生成物
をシリカゲルカラムクロマトグラフィー[ヘキサン:酢
酸エチル=4:1(v/v)にて溶出]にて精製し、化
合物(15)及び化合物(16)の混合物を0.40g
(収率97%)得た。この混合物の一部をシリカゲルカ
ラムクロマトグラフィー[ヘキサン:酢酸エチル=5:
1(v/v)にて溶出]にて分離し、先に溶出する画分
から無色粉末(16)を得、後から溶出する画分から無
色粉末(15)を得た。
15) Compound (15) and Compound (16)
Synthesis of Compound (14) To 0.41 g of compound (14) was added 16 ml of 0.01N hydrogen chloride-ethyl acetate solution, and the mixture was stirred at room temperature for 1 hour. A saturated aqueous solution of sodium hydrogencarbonate was added to the reaction solution, extracted with ethyl acetate, washed with saturated saline, and then dried over anhydrous magnesium sulfate. The crude product obtained by distilling off the solvent was purified by silica gel column chromatography [eluting with hexane: ethyl acetate = 4: 1 (v / v)] to give compound (15) and compound (16). 0.40g of mixture
(Yield 97%) was obtained. A part of this mixture was subjected to silica gel column chromatography [hexane: ethyl acetate = 5:
Elution at 1 (v / v)], and colorless powder (16) was obtained from the fraction eluting first, and colorless powder (15) was obtained from the fraction eluting later.

【0069】化合物(15) mp:68〜70℃ IR(KBr)cm-1:3502,1714,1371,12681 H−NMR(CDCl3)δ:0.82(3H,s),0.89(3H,d,J
=6Hz),0.91(3H,d,J=6Hz),0.93(3H,s),1.92(3H,s),2.33
(1H,dd,J=10 and 8Hz),3.92(4H,s),3.98〜4.08(1H,m),
4.67(1H,dd,J=10 and 5Hz),4.97(1H,s),5.02(1H,s) LSIMS(+KI) m/z:527(MK+)。
Compound (15) mp: 68 to 70 ° C. IR (KBr) cm −1 : 3502,1714,1371,1268 1 H-NMR (CDCl 3 ) δ: 0.82 (3H, s), 0.89 (3H, d) , J
= 6Hz), 0.91 (3H, d, J = 6Hz), 0.93 (3H, s), 1.92 (3H, s), 2.33
(1H, dd, J = 10 and 8Hz), 3.92 (4H, s), 3.98 ~ 4.08 (1H, m),
4.67 (1H, dd, J = 10 and 5Hz), 4.97 (1H, s), 5.02 (1H, s) LSIMS (+ KI) m / z: 527 (MK + ).

【0070】化合物(16) mp:143〜149℃ IR(KBr)cm-1:3508,1737,1368,12401 H−NMR(CDCl3)δ:0.78(3H,s),0.83(3H,s),
0.91(3H,d,J=6Hz),0.93(3H,d,J=6Hz),2.06(3H,s),2.22
(1H,t,J=10Hz),3.47(1H,dd,J=10 and 5Hz),3.93(4H,s),
5.17(1H,s),5.27(1H,s),5.40(1H,t,J=6Hz) LSIMS(+KI) m/z:527(MK+)。
Compound (16) mp: 143-149 ° C IR (KBr) cm -1 : 3508,1737,1368,1240 1 H-NMR (CDCl 3 ) δ: 0.78 (3H, s), 0.83 (3H, s) ),
0.91 (3H, d, J = 6Hz), 0.93 (3H, d, J = 6Hz), 2.06 (3H, s), 2.22
(1H, t, J = 10Hz), 3.47 (1H, dd, J = 10 and 5Hz), 3.93 (4H, s),
5.17 (1H, s), 5.27 (1H, s), 5.40 (1H, t, J = 6Hz) LSIMS (+ KI) m / z: 527 (MK + ).

【0071】16)化合物(10)の合成 化合物(15)と化合物(16)の混合物3.08gを
メタノール90mlに溶解し、無水炭酸カリウム1.7
5gを加え、室温にて10時間撹拌した。反応液を留去
して得られた残渣に水を加え、塩化メチレンにて抽出
後、飽和食塩水にて洗浄して無水硫酸マグネシウムにて
乾燥した。溶媒を留去して得られた粗生成物をシリカゲ
ルカラムクロマトグラフィー[塩化メチレン:酢酸エチ
ル=4:1(v/v)にて溶出]にて精製し、化合物
(10)を2.72g(97%)得た。
16) Synthesis of compound (10) 3.08 g of a mixture of compound (15) and compound (16) was dissolved in 90 ml of methanol and anhydrous potassium carbonate 1.7 was added.
5 g was added, and the mixture was stirred at room temperature for 10 hours. Water was added to the residue obtained by distilling off the reaction solution, extracted with methylene chloride, washed with saturated brine and dried over anhydrous magnesium sulfate. The crude product obtained by distilling off the solvent was purified by silica gel column chromatography [eluting with methylene chloride: ethyl acetate = 4: 1 (v / v)] to obtain 2.72 g of compound (10) ( 97%).

【0072】17)化合物(17)及び化合物(18)
の合成 化合物(5)0.2gを窒素雰囲気下、塩化メチレン6.
5mlに溶解後、酸化バナジウムアセチルアセトネート
0.001gを加え氷水浴中で冷却した。この溶液にter
t−ブチルハイドロパーオキシド(3.3規定塩化メチレ
ン溶液)0.25mlを加え、1時間撹拌後、室温にて
5時間撹拌した。反応液を塩化メチレンにて希釈し、フ
ロリジルを加えてシリカゲルのショートカラム[酢酸エ
チルにて溶出]を通過させて粗生成物を得た。これをシ
リカゲルカラムクロマトグラフィー[クロロホルム:酢
酸エチル=5:1(v/v)にて溶出]にて精製し、無
色粉末の化合物(17)及び化合物(18)の混合物を
0.19g得た[1H−NMRスペクトルより副生成物
(18)を約10%含有]。なお、本混合物を酢酸エチ
ル−ヘキサンにて再結晶することにより、化合物(1
7)の単品を0.15g(収率72%)得た。
17) Compound (17) and Compound (18)
Synthesis of Compound (5) 0.2 g of methylene chloride under nitrogen atmosphere 6.
After dissolving in 5 ml, vanadium oxide acetylacetonate (0.001 g) was added and the mixture was cooled in an ice-water bath. Ter this solution
0.25 ml of t-butyl hydroperoxide (3.3N methylene chloride solution) was added, and the mixture was stirred for 1 hour and then at room temperature for 5 hours. The reaction solution was diluted with methylene chloride, florisil was added, and the mixture was passed through a silica gel short column [eluted with ethyl acetate] to obtain a crude product. This was purified by silica gel column chromatography [eluting with chloroform: ethyl acetate = 5: 1 (v / v)] to obtain 0.19 g of a colorless powdery mixture of compound (17) and compound (18). Approximately 10% of by-product (18) is contained from 1 H-NMR spectrum]. By recrystallizing this mixture with ethyl acetate-hexane, the compound (1
0.15 g (yield 72%) of a single product of 7) was obtained.

【0073】化合物(17) mp:204〜207℃ Anal.Calcd for C26443:C,77.18;
H,10.96 Found:C,77.14;H,11.11 IR(KBr)cm-1:3386,3284,2948,2871,10451 H−NMR(CDCl3)δ:0.70(3H,s),0.78(3H,s),
0.95(3H,d,J=4Hz),0.98(3H,d,J=4Hz),1.27(3H,s),3.23
(1H,dd,J=12 and 5Hz),3.35(1H,t,J=6Hz),3.48〜3.67(1
H,m),4.50(1H,s) LSIMS(+KI) m/z:443(MK+)。
Compound (17) mp: 204 to 207 ° C. Anal.Calcd for C 26 H 44 O 3 : C, 77.18;
H, 10.96 Found: C, 77.14; H, 11.11 IR (KBr) cm -1 : 3386,3284,2948,2871,1045 1 H-NMR (CDCl 3 ) δ: 0.70 (3H, s), 0.78 (3H, s),
0.95 (3H, d, J = 4Hz), 0.98 (3H, d, J = 4Hz), 1.27 (3H, s), 3.23
(1H, dd, J = 12 and 5Hz), 3.35 (1H, t, J = 6Hz), 3.48-3.67 (1
H, m), 4.50 (1H, s) LSIMS (+ KI) m / z: 443 (MK + ).

【0074】化合物(18)1 H−NMR(CDCl3)δ:0.82(3H,s),0.84(3H,s),
0.93(3H,d,J=5Hz),0.97(3H,d,J=5Hz),2.75(1H,t,J=6H
z),3.17(1H,dd,J=12 and 5Hz),3.49〜3.67(1H,m),4.42
(1H,s)。
Compound (18) 1 H-NMR (CDCl 3 ) δ: 0.82 (3H, s), 0.84 (3H, s),
0.93 (3H, d, J = 5Hz), 0.97 (3H, d, J = 5Hz), 2.75 (1H, t, J = 6H
z), 3.17 (1H, dd, J = 12 and 5Hz), 3.49-3.67 (1H, m), 4.42
(1H, s).

【0075】18)化合物(19)の合成 実施例の7)に記載の製法に準拠し、化合物(17)か
ら無色粉末(19)を得た。 mp:224〜226℃ Anal.Calcd for C26443:C,77.18;
H,10.96 Found:C,77.28;H,11.16 IR(KBr)cm-1:3368,2953,2931,2868,14681 H−NMR(CDCl3)δ:0.75(3H,s),0.84(3H,s),
0.91(3H,d,J=6Hz),0.93(3H,d,J=6Hz),2.35(1H,t,J=10H
z),3.07(1H,brs),3.48(1H,dd,J=11Hz and 5Hz),3.50〜
3.70(1H,m),3.68(1H,brs),4.27(1H,t,J=7Hz),4.95(1H,
s),5.11(1H,s) FABMS(+KI) m/z:443(MK+)。
18) Synthesis of Compound (19) According to the production method described in Example 7), a colorless powder (19) was obtained from the compound (17). mp: 224~226 ℃ Anal.Calcd for C 26 H 44 O 3: C, 77.18;
H, 10.96 Found: C, 77.28; H, 11.16 IR (KBr) cm -1 : 3368,2953,2931,2868,1468 1 H-NMR (CDCl 3 ) δ: 0.75 (3H, s), 0.84 (3H, s),
0.91 (3H, d, J = 6Hz), 0.93 (3H, d, J = 6Hz), 2.35 (1H, t, J = 10H
z), 3.07 (1H, brs), 3.48 (1H, dd, J = 11Hz and 5Hz), 3.50 ~
3.70 (1H, m), 3.68 (1H, brs), 4.27 (1H, t, J = 7Hz), 4.95 (1H,
s), 5.11 (1H, s) FABMS (+ KI) m / z: 443 (MK + ).

【0076】19)化合物(20)の合成 実施例の8)に記載の製法に準拠し、化合物(19)か
ら無色粉末(20)を得た。 mp:169〜171℃ Anal.Calcd for C26444:C,74.24;
H,10.54 Found:C,74.19;H,10.76 IR(KBr)cm-1:3478,3288,2934,2858,10301 H−NMR(CDCl3)δ:0.67(3H,s),0.79(3H,s),
0.92(3H,d,J=6Hz),0.94(3H,d,J=6Hz),2.13(1H,t,J=8H
z),2.87(1H,d,J=4Hz),3.06(1H,d,J=4Hz),3.36(1H,dd,J=
12 and 5Hz),3.42(1H,dd,J=10 and 4Hz),3.49〜3.67(1
H,m) FABMS(+KI) m/z:459(MK+) 高分解能FABMS(+KI) m/z:Calcd
for C26444 K:459.2877 Found:459.2870。
19) Synthesis of Compound (20) A colorless powder (20) was obtained from the compound (19) according to the production method described in Example 8). mp: 169~171 ℃ Anal.Calcd for C 26 H 44 O 4: C, 74.24;
H, 10.54 Found: C, 74.19; H, 10.76 IR (KBr) cm −1 : 3478,3288,2934,2858,1030 1 H-NMR (CDCl 3 ) δ: 0.67 (3H, s), 0.79 (3H, s),
0.92 (3H, d, J = 6Hz), 0.94 (3H, d, J = 6Hz), 2.13 (1H, t, J = 8H
z), 2.87 (1H, d, J = 4Hz), 3.06 (1H, d, J = 4Hz), 3.36 (1H, dd, J =
12 and 5Hz), 3.42 (1H, dd, J = 10 and 4Hz), 3.49 ~ 3.67 (1
H, m) FABMS (+ KI) m / z: 459 (MK + ) High resolution FABMS (+ KI) m / z: Calcd
for C 26 H 44 O 4 K : 459.2877 Found: 459.2870.

【0077】以下、化合物(19)の別途合成について
記載する。 20)化合物(21)の合成 実施例の14)に記載の製法に準拠し、化合物(17)
から無色非晶質(21)を得た。 Anal.Calcd for C30485:C,73.73;
H,9.90 Found:C,73.73;H,9.98 IR(KBr)cm-1:2955,1737,1468,1370,1245,102
41 H−NMR(CDCl3)δ:0.83(3H,s),0.86(3H,s),
0.95(3H,d,J=7Hz),0.96(3H,d,J=7Hz),1.24(3H,s),2.01
(3H,s),2.04(3H,s),2.61(1H,dd,J=9 and 2Hz),4.56〜4.
77(2H,m) LSIMS m/z:489(MH+)。
The separate synthesis of compound (19) is described below. 20) Synthesis of compound (21) According to the production method described in Example 14), compound (17)
From this, colorless amorphous (21) was obtained. Anal. Calcd for C 30 H 48 O 5 : C, 73.73;
H, 9.90 Found: C, 73.73; H, 9.98 IR (KBr) cm -1 : 2955,1737,1468,1370,1245,102
4 1 H-NMR (CDCl 3 ) δ: 0.83 (3H, s), 0.86 (3H, s),
0.95 (3H, d, J = 7Hz), 0.96 (3H, d, J = 7Hz), 1.24 (3H, s), 2.01
(3H, s), 2.04 (3H, s), 2.61 (1H, dd, J = 9 and 2Hz), 4.56〜4.
77 (2H, m) LSIMS m / z: 489 (MH + ).

【0078】21)化合物(22)及び化合物(23)
の合成 実施例の15)に記載の製法に準拠し、化合物(21)
から無色非晶質(22)及び無色粉末(23)を得た。 化合物(22) Anal.Calcd for C30485:C,73.73;
H,9.90 Found:C,73.72;H,10.06 IR(KBr)cm-1:3510,2956,1738,1718,1248,102
81 H−NMR(CDCl3)δ:0.83(3H,s),0.90(3H,d,J
=6Hz),0.92(3H,d,J=6Hz),0.93(3H,s),1.93(3H,s),2.01
(3H,s),2.32(1H,t,J=10Hz),3.97〜4.08(1H,m),4.58〜4.
76(2H,m),4.97(1H,s),5.03(1H,s) LSIMS(+KI) m/z:527(MK+)。
21) Compound (22) and Compound (23)
According to the production method described in Example 15), compound (21)
From this, colorless amorphous (22) and colorless powder (23) were obtained. Compound (22) Anal.Calcd for C 30 H 48 O 5 : C, 73.73;
H, 9.90 Found: C, 73.72; H, 10.06 IR (KBr) cm -1 : 3510,2956,1738,1718,1248,102
8 1 H-NMR (CDCl 3 ) δ: 0.83 (3H, s), 0.90 (3H, d, J
= 6Hz), 0.92 (3H, d, J = 6Hz), 0.93 (3H, s), 1.93 (3H, s), 2.01
(3H, s), 2.32 (1H, t, J = 10Hz), 3.97 ~ 4.08 (1H, m), 4.58 ~ 4.
76 (2H, m), 4.97 (1H, s), 5.03 (1H, s) LSIMS (+ KI) m / z: 527 (MK + ).

【0079】化合物(23) mp:128〜130℃ Anal.Calcd for C30485:C,73.73;
H,9.90 Found:C,73.86;H,10.02 IR(KBr)cm-1:3470,2954,1734,1714,1264,102
41 H−NMR(CDCl3)δ:0.80(3H,s),0.85(3H,s),
0.93(3H,d,J=6Hz),0.95(3H,d,J=6Hz),2.04(3H,s),2.08
(3H,s),2.23(1H,t,J=10Hz),3.50(1H,dd,J=11 and 6Hz),
4.57〜4.78(1H,m),5.18(1H,s),5.28(1H,s),5.42(1H,t,J
=6Hz) LSIMS(+KI) m/z:527(MK+)。
Compound (23) mp: 128 to 130 ° C. Anal.Calcd for C 30 H 48 O 5 : C, 73.73;
H, 9.90 Found: C, 73.86; H, 10.02 IR (KBr) cm -1 : 3470,2954,1734,1714,1264,102
4 1 H-NMR (CDCl 3 ) δ: 0.80 (3H, s), 0.85 (3H, s),
0.93 (3H, d, J = 6Hz), 0.95 (3H, d, J = 6Hz), 2.04 (3H, s), 2.08
(3H, s), 2.23 (1H, t, J = 10Hz), 3.50 (1H, dd, J = 11 and 6Hz),
4.57 to 4.78 (1H, m), 5.18 (1H, s), 5.28 (1H, s), 5.42 (1H, t, J
= 6 Hz) LSIMS (+ KI) m / z: 527 (MK + ).

【0080】22)化合物(19)の合成 実施例の16)に記載の製法に準拠し、化合物(22)
及び化合物(23)の混合物から無色粉末(19)を得
た。
22) Synthesis of Compound (19) Compound (22) was prepared according to the production method described in Example 16).
A colorless powder (19) was obtained from the mixture of and (23).

【0081】23)化合物(24)の合成[図4におけ
る(24)のArが4−ニトロフェニルの場合] 化合物(5)2.50g、4−ニトロ安息香酸1.29g
及びトリフェニルホスフィン2.02gをテトラヒドロ
フラン25mlに溶解し、氷冷下にてジエチルアゾジカ
ルボキシレート1.32mlを滴下し、窒素雰囲気下、
室温にて2時間撹拌した。反応終了後、溶媒を減圧留去
して得られた残渣をシリカゲルカラムクロマトグラフィ
ー[ヘキサン:酢酸エチル=8:1(V/V)にて溶
出]に付し、淡黄色非晶質(24)を3.05g(収率
88.2%)得た。
23) Synthesis of Compound (24) [When Ar of (24) in FIG. 4 is 4-nitrophenyl] 2.50 g of Compound (5), 1.29 g of 4-nitrobenzoic acid
And 2.02 g of triphenylphosphine are dissolved in 25 ml of tetrahydrofuran, 1.32 ml of diethyl azodicarboxylate is added dropwise under ice cooling, and under nitrogen atmosphere,
The mixture was stirred at room temperature for 2 hours. After completion of the reaction, the solvent was distilled off under reduced pressure and the obtained residue was subjected to silica gel column chromatography [hexane: ethyl acetate = elute with 8: 1 (V / V)] to give a pale yellow amorphous substance (24). Was obtained (3.08 g, yield 88.2%).

【0082】IR(KBr)cm-1:3558,2952,2869,1
723,1530,1347,12771 H−NMR(CDCl3)δ:0.75(3H,s),0.87(3H,s),
0.88(3H,d,J=6Hz),0.89(3H,d,J=6Hz),1.68(3H,s),2.30
(1H,t,J=9Hz),3.63(1H,dd,J=11 and 5Hz),5.32(1H,br
s),5.51(1H,t,J=7Hz),8.16〜8.36(4H,m) FABMS(+KI) m/z:576(MK+)。
IR (KBr) cm -1 : 3558,2952,2869,1
723,1530,1347,1277 1 H-NMR (CDCl 3 ) δ: 0.75 (3H, s), 0.87 (3H, s),
0.88 (3H, d, J = 6Hz), 0.89 (3H, d, J = 6Hz), 1.68 (3H, s), 2.30
(1H, t, J = 9Hz), 3.63 (1H, dd, J = 11 and 5Hz), 5.32 (1H, br
s), 5.51 (1H, t, J = 7Hz), 8.16 to 8.36 (4H, m) FABMS (+ KI) m / z: 576 (MK + ).

【0083】24)化合物(25)の合成 化合物(24)0.109gをメタノール1.0ml及び
テトラヒドロフラン0.5mlの混合溶媒に溶解し、無
水炭酸カリウム0.06gを加えて室温にて3時間撹拌
した。反応終了後、反応液に水を加え、酢酸エチルにて
抽出し、飽和食塩水にて洗浄後、無水硫酸マグネシウム
にて乾燥した。溶媒を減圧留去して得られた残渣をシリ
カゲルカラムクロマトグラフィー[ヘキサン:酢酸エチ
ル=4:1(V/V)にて溶出]に付し、無色粉末(2
5)を0.062g(収率78.8%)得た。
24) Synthesis of compound (25) 0.109 g of compound (24) was dissolved in a mixed solvent of 1.0 ml of methanol and 0.5 ml of tetrahydrofuran, 0.06 g of anhydrous potassium carbonate was added, and the mixture was stirred at room temperature for 3 hours. did. After completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate, washed with saturated saline solution, and dried with anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the obtained residue was subjected to silica gel column chromatography [eluting with hexane: ethyl acetate = 4: 1 (V / V)] to give a colorless powder (2
5) was obtained (0.062 g, yield 78.8%).

【0084】mp:158〜162℃ Anal.Calcd for C26442:C,80.35;
H,11.41 Found:C,80.31;H,11.40 IR(KBr)cm-1:3556,3325,2953,2926,1466,144
7,13831 H−NMR(CDCl3)δ:0.74(3H,s),0.78(3H,s),
0.89(6H,d,J=6Hz),1.68(3H,s),1.91(2H,t,J=6Hz),2.30
(1H,t,J=10Hz),2.39(1H,brs),3.60(1H,dd,J=11and 5H
z),4.00〜4.08(1H,m),5.52(1H,t,J=6Hz) LSIMS(+KI) m/z:427(MK+)。
Mp: 158-162 ° C. Anal.Calcd for C 26 H 44 O 2 : C, 80.35;
H, 11.41 Found: C, 80.31; H, 11.40 IR (KBr) cm -1 : 3556,3325,2953,2926,1466,144
7,1383 1 H-NMR (CDCl 3 ) δ: 0.74 (3H, s), 0.78 (3H, s),
0.89 (6H, d, J = 6Hz), 1.68 (3H, s), 1.91 (2H, t, J = 6Hz), 2.30
(1H, t, J = 10Hz), 2.39 (1H, brs), 3.60 (1H, dd, J = 11and 5H
z), 4.00 to 4.08 (1H, m), 5.52 (1H, t, J = 6Hz) LSIMS (+ KI) m / z: 427 (MK + ).

【0085】25)化合物(26)、化合物(27)及
び化合物(28)の合成 a)炭酸水素ナトリウム非存在下の場合 化合物(25)0.1176gを塩化メチレン2.5ml
に溶解し、酸化バナジウムアセチルアセトネート0.0
08gを加え、窒素雰囲気下、氷水浴にて冷却した。こ
の溶液にtert−ブチルハイドロパーオキシド(3.86
M塩化メチレン溶液)0.24mlを滴下し、氷冷下に
て1時間更に室温にて1.5時間撹拌した。反応液に水
を加え、酢酸エチルにて抽出し、飽和食塩水にて洗浄
後、無水硫酸マグネシウムにて乾燥した。溶媒を減圧留
去して得られた残渣をシリカゲルフラッシュカラムクロ
マトグラフィー[ヘキサン:酢酸エチル=3:1(V/
V)にて溶出]に付し、先に溶出する画分から無色粉末
(28)を0.0168g(収率13.7%)、次に溶出
する画分から無色粉末(27)を0.0062g(収率
5.1%)、最後に溶出する画分から無色非晶質(2
6)を0.0877g(収率71.7%)得た。
25) Synthesis of compound (26), compound (27) and compound (28) a) In the absence of sodium hydrogencarbonate 0.1176 g of compound (25) in 2.5 ml of methylene chloride
Dissolved in vanadium oxide acetylacetonate 0.0
08 g was added, and the mixture was cooled in an ice water bath under a nitrogen atmosphere. Tert-Butyl hydroperoxide (3.86
Methylene chloride solution) (0.24 ml) was added dropwise, and the mixture was stirred under ice cooling for 1 hour and further at room temperature for 1.5 hours. Water was added to the reaction solution, which was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure and the obtained residue was subjected to silica gel flash column chromatography [hexane: ethyl acetate = 3: 1 (V /
V), and 0.0168 g (yield 13.7%) of colorless powder (28) from the fraction to be eluted first, and 0.0062 g of colorless powder (27) from the fraction to be eluted next. Yield 5.1%), colorless amorphous (2%
6) was obtained in an amount of 0.0877 g (yield: 71.7%).

【0086】b)炭酸水素ナトリウム存在下の場合 化合物(25)0.221gを塩化メチレン5.7mlに
溶解し、酸化バナジウムアセチルアセトネート0.01
5g及び炭酸水素ナトリウム0.144gを加え、窒素
雰囲気下、氷水浴にて冷却した。この溶液にtert−ブチ
ルハイドロパーオキシド(3.86M塩化メチレン溶
液)0.445mlを滴下し、氷冷下にて4時間撹拌し
た。反応液に飽和炭酸水素ナトリウム水溶液を加え、酢
酸エチルにて抽出し、飽和食塩水にて洗浄後、無水硫酸
マグネシウムにて乾燥した。溶媒を減圧留去して得られ
た残渣をシリカゲルフラッシュカラムクロマトグラフィ
ー[ヘキサン:酢酸エチル=3:1(V/V)にて溶
出]に付し、先に溶出する画分から化合物(28)及び
化合物(27)の混合物を0.018g(収率8.6
%)、後から溶出する画分から化合物(26)を0.1
76g(収率84.2%)得た。
B) In the presence of sodium hydrogen carbonate 0.221 g of compound (25) was dissolved in 5.7 ml of methylene chloride, and vanadium oxide acetylacetonate 0.01
5 g and 0.144 g of sodium hydrogen carbonate were added, and the mixture was cooled in an ice-water bath under a nitrogen atmosphere. To this solution, 0.445 ml of tert-butyl hydroperoxide (3.86 M methylene chloride solution) was added dropwise, and the mixture was stirred for 4 hours under ice cooling. A saturated aqueous sodium hydrogen carbonate solution was added to the reaction solution, extracted with ethyl acetate, washed with saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the obtained residue was subjected to silica gel flash column chromatography [eluted with hexane: ethyl acetate = 3: 1 (V / V)] to give compound (28) and compound (28) from the fraction eluted first. 0.018 g of a mixture of compound (27) (yield 8.6
%), 0.1% of compound (26) from the fraction eluted later.
76 g (yield 84.2%) was obtained.

【0087】化合物(26) Anal.Calcd for C26443:C,77.18;
H,10.96 Found:C,77.36;H,10.99 IR(KBr)cm-1:3571,3339,2924,1468,1385,102
5,10071 H−NMR(CDCl3)δ:0.71(3H,s),0.76(3H,s),
0.96(3H,d,J=6Hz),0.97(3H,d,J=6Hz),1.27(3H,s),3.24
(1H,dd,J=11 and 5Hz),3.35(1H,t,J=6Hz),4.04(1H,br
s),4.50(1H,s,exchangeable) FABMS(+KI) m/z:443(MK+)。
Compound (26) Anal.Calcd for C 26 H 44 O 3 : C, 77.18;
H, 10.96 Found: C, 77.36; H, 10.99 IR (KBr) cm -1 : 3571,3339,2924,1468,1385,102
5,1007 1 H-NMR (CDCl 3 ) δ: 0.71 (3H, s), 0.76 (3H, s),
0.96 (3H, d, J = 6Hz), 0.97 (3H, d, J = 6Hz), 1.27 (3H, s), 3.24
(1H, dd, J = 11 and 5Hz), 3.35 (1H, t, J = 6Hz), 4.04 (1H, br
s), 4.50 (1H, s, exchangeable) FABMS (+ KI) m / z: 443 (MK + ).

【0088】化合物(27) mp:158〜162℃ Anal.Calcd for C26443:C,77.18;
H,10.96 Found:C,76.95;H,10.97 IR(KBr)cm-1:3436,2927,2872,1468,1386,102
9,10061 H−NMR(CDCl3)δ:0.79(3H,s),0.84(3H,s),
0.94(3H,d,J=6Hz),0.97(3H,d,J=6Hz),1.28(3H,s),2.76
(1H,t,J=5Hz),3.18(1H,dd,J=11 and 5Hz),4.00〜4.08(1
H,m),4.44(1H,s,exchangeable) FABMS(+KI) m/z:443(MK+)。
Compound (27) mp: 158-162 ° C. Anal.Calcd for C 26 H 44 O 3 : C, 77.18;
H, 10.96 Found: C, 76.95; H, 10.97 IR (KBr) cm -1 : 3436,2927,2872,1468,1386,102
9,1006 1 H-NMR (CDCl 3 ) δ: 0.79 (3H, s), 0.84 (3H, s),
0.94 (3H, d, J = 6Hz), 0.97 (3H, d, J = 6Hz), 1.28 (3H, s), 2.76
(1H, t, J = 5Hz), 3.18 (1H, dd, J = 11 and 5Hz), 4.00 ~ 4.08 (1
H, m), 4.44 (1H, s, exchangeable) FABMS (+ KI) m / z: 443 (MK + ).

【0089】化合物(28) mp:225〜227℃ Anal.Calcd for C26443:C,77.18;
H,10.96 Found:C,77.15;H,10.99 IR(KBr)cm-1:3401,2950,2917,2869,1070,100
11 H−NMR(CDCl3)δ:0.61(3H,s),0.81(3H,s),
0.90(3H,d,J=6Hz),0.96(3H,d,J=6Hz),1.13(3H,s),2.94
(1H,dd,J=11 and 5Hz),3.09(1H,dd,J=10 and 3Hz),4.03
(1H,brs) FABMS(+KI) m/z:443(MK+)。
Compound (28) mp: 225-227 ° C. Anal.Calcd for C 26 H 44 O 3 : C, 77.18;
H, 10.96 Found: C, 77.15; H, 10.99 IR (KBr) cm -1 : 3401,2950,2917,2869,1070,100
1 1 H-NMR (CDCl 3 ) δ: 0.61 (3H, s), 0.81 (3H, s),
0.90 (3H, d, J = 6Hz), 0.96 (3H, d, J = 6Hz), 1.13 (3H, s), 2.94
(1H, dd, J = 11 and 5Hz), 3.09 (1H, dd, J = 10 and 3Hz), 4.03
(1H, brs) FABMS (+ KI) m / z: 443 (MK + ).

【0090】26)化合物(29)の合成 実施例の7)に記載の製法に準拠し、化合物(26)か
ら無色粉末(29)を得た。 mp:110〜113℃ Anal.Calcd for C26443:C,77.18;
H,10.96 Found:C,77.05;H,11.24 IR(KBr)cm-1:3339,2926,1639,1469,1023,100
3,9061 H−NMR(CDCl3)δ:0.74(3H,s),0.79(3H,s),
0.89(3H,d,J=6Hz),0.91(3H,d,J=6Hz),2.33(1H,t,J=9H
z),3.53(1H,dd,J=11 and 4Hz),4.05(1H,brs),4.24(1H,
t,J=6Hz),4.93(1H,s),5.08(1H,s) FABMS(+KI) m/z:443(MK+)。
26) Synthesis of Compound (29) According to the production method described in Example 7), colorless powder (29) was obtained from compound (26). mp: 110~113 ℃ Anal.Calcd for C 26 H 44 O 3: C, 77.18;
H, 10.96 Found: C, 77.05; H, 11.24 IR (KBr) cm -1 : 3339,2926,1639,1469,1023,100
3,906 1 H-NMR (CDCl 3 ) δ: 0.74 (3H, s), 0.79 (3H, s),
0.89 (3H, d, J = 6Hz), 0.91 (3H, d, J = 6Hz), 2.33 (1H, t, J = 9H
z), 3.53 (1H, dd, J = 11 and 4Hz), 4.05 (1H, brs), 4.24 (1H,
t, J = 6Hz), 4.93 (1H, s), 5.08 (1H, s) FABMS (+ KI) m / z: 443 (MK + ).

【0091】27)化合物(30)の合成 実施例の8)に記載の製法に準拠し、化合物(29)か
ら無色微細針状晶(30)を得た。 mp:201〜203℃ Anal.Calcd for C26444:C,74.24;
H,10.54 Found:C,74.48;H,10.72 IR(KBr)cm-1:3435,2922,2869,10051 H−NMR(CDCl3)δ:0.68(3H,s),0.76(3H,s),
0.90(3H,d,J=7Hz),0.95(3H,d,J=7Hz),2.18(1H,t,J=10H
z),2.44(1H,d,J=5Hz,exchangeable),2.85(1H,d,J=4Hz),
3.05(1H,d,J=4Hz),3.32〜3.48(2H,m),4.04(1H,brs),4.2
5(1H,s,exchangeable) FABMS(+KI) m/z:459(MK+)。
27) Synthesis of Compound (30) According to the production method described in Example 8), colorless fine needle crystals (30) were obtained from compound (29). mp: 201~203 ℃ Anal.Calcd for C 26 H 44 O 4: C, 74.24;
H, 10.54 Found: C, 74.48; H, 10.72 IR (KBr) cm −1 : 3435,2922,2869,1005 1 H-NMR (CDCl 3 ) δ: 0.68 (3H, s), 0.76 (3H, s) ,
0.90 (3H, d, J = 7Hz), 0.95 (3H, d, J = 7Hz), 2.18 (1H, t, J = 10H
z), 2.44 (1H, d, J = 5Hz, exchangeable), 2.85 (1H, d, J = 4Hz),
3.05 (1H, d, J = 4Hz), 3.32 ~ 3.48 (2H, m), 4.04 (1H, brs), 4.2
5 (1H, s, exchangeable) FABMS (+ KI) m / z: 459 (MK + ).

【0092】以下、化合物(29)の別途合成について
記載する。 28)化合物(31)の合成 実施例の14)に記載の製法に準拠し、化合物(26)
から無色粉末(31)を得た。 mp:131〜134℃ Anal.Calcd for C30485:C,73.73;
H,9.90 Found:C,73.93;H,10.06 IR(KBr)cm-1:2960,2933,2875,1736,12451 H−NMR(DMSO−d6)δ:0.76(3H,s),0.81(3
H,s),0.90(6H,d,J=6Hz),1.98(3H,s),2.00(3H,s),2.44(1
H,dd,J=8 and 3Hz),4.52(1H,dd,J=11 and 5Hz),4.87(1
H,brs) FABMS(+KI) m/z:527(MK+)。
The separate synthesis of compound (29) is described below. 28) Synthesis of compound (31) Compound (26) was prepared according to the production method described in Example 14).
A colorless powder (31) was obtained from mp: 131~134 ℃ Anal.Calcd for C 30 H 48 O 5: C, 73.73;
H, 9.90 Found: C, 73.93; H, 10.06 IR (KBr) cm -1 : 2960,2933,2875,1736,1245 1 H-NMR (DMSO-d 6 ) δ: 0.76 (3H, s), 0.81 ( 3
H, s), 0.90 (6H, d, J = 6Hz), 1.98 (3H, s), 2.00 (3H, s), 2.44 (1
H, dd, J = 8 and 3Hz), 4.52 (1H, dd, J = 11 and 5Hz), 4.87 (1
H, brs) FABMS (+ KI) m / z: 527 (MK + ).

【0093】29)化合物(32)及び化合物(33)
の合成 実施例の15)に記載の製法に準拠し、化合物(31)
から無色粉末(32)及び無色粉末(33)を得た。 化合物(32) mp:171〜172℃ Anal.Calcd for C30485:C,73.73;
H,9.90 Found:C,73.54;H,9.98 IR(KBr)cm-1:3548,2958,1733,1715,1261,123
61 H−NMR(CDCl3)δ:0.80(3H,s),0.91(3H,d,J
=7Hz),0.92(3H,d,J=7Hz),0.94(3H,s),1.93(3H,s),2.05
(3H,s),2.32(1H,t,J=9Hz),4.02(1H,dd,J=9 and5Hz),4.6
6(1H,dd,J=11 and 5Hz),4.98(1H,s),5.00(1H,brs),5.02
(1H,s) FABMS(+KI) m/z:527(MK+)。
29) Compound (32) and Compound (33)
Synthesis of compound (31) according to the production method described in Example 15).
From this, colorless powder (32) and colorless powder (33) were obtained. Compound (32) mp: 171-172 ° C Anal.Calcd for C 30 H 48 O 5 : C, 73.73;
H, 9.90 Found: C, 73.54; H, 9.98 IR (KBr) cm -1 : 3548,2958,1733,1715,1261,123
6 1 H-NMR (CDCl 3 ) δ: 0.80 (3H, s), 0.91 (3H, d, J
= 7Hz), 0.92 (3H, d, J = 7Hz), 0.94 (3H, s), 1.93 (3H, s), 2.05
(3H, s), 2.32 (1H, t, J = 9Hz), 4.02 (1H, dd, J = 9 and 5Hz), 4.6
6 (1H, dd, J = 11 and 5Hz), 4.98 (1H, s), 5.00 (1H, brs), 5.02
(1H, s) FABMS (+ KI) m / z: 527 (MK + ).

【0094】化合物(33) mp:114〜116℃ IR(KBr)cm-1:3535,2952,2871,1736,1371,124
5,10211 H−NMR(CDCl3)δ:0.78(3H,s),0.81(3H,s),
0.91(3H,d,J=6Hz),0.93(3H,d,J=6Hz),2.04(3H,s),2.06
(3H,s),2.22(1H,t,J=9Hz),3.42〜3.55(1H,m),5.02(1H,b
rs),5.18(1H,s),5.27(1H,s),5.41(1H,t,J=6Hz) FABMS(+KI) m/z:527(MK+)。
Compound (33) mp: 114-116 ° C. IR (KBr) cm −1 : 3535,2952,2871,1736,1371,124
5,1021 1 H-NMR (CDCl 3 ) δ: 0.78 (3H, s), 0.81 (3H, s),
0.91 (3H, d, J = 6Hz), 0.93 (3H, d, J = 6Hz), 2.04 (3H, s), 2.06
(3H, s), 2.22 (1H, t, J = 9Hz), 3.42-3.55 (1H, m), 5.02 (1H, b
rs), 5.18 (1H, s), 5.27 (1H, s), 5.41 (1H, t, J = 6Hz) FABMS (+ KI) m / z: 527 (MK + ).

【0095】30)化合物(29)の合成 実施例の16)に記載の製法に準拠し、化合物(32)
及び化合物(33)の混合物から無色粉末(29)を得
た。 31)化合物(34)の合成 化合物(12)0.060gをテトラヒドロフラン1.5
mlに溶解し、アルゴン雰囲気下、文献(Tetrah
edron Letters,第27巻,第3697
頁,1986年)記載の方法にて調製したLi2CuC
4のテトラヒドロフラン溶液(1mol/l)0.29
mlを加え、室温にて1.5時間撹拌した。反応液に酢
酸エチルを加え、水及び飽和食塩水にて順次洗浄後、無
水硫酸マグネシウムにて乾燥した。溶媒を減圧下留去し
て得られた粗生成物をシリカゲルカラムクロマトグラフ
ィー[塩化メチレン:アセトン=6:1(V/V)にて
溶出]に付し、無色非晶質(34)を0.063g(収
率97.0%)得た。
30) Synthesis of compound (29) Compound (32) was prepared according to the production method described in Example 16).
A colorless powder (29) was obtained from the mixture of and (33). 31) Synthesis of compound (34) 0.060 g of compound (12) was added to tetrahydrofuran 1.5
Dissolve in ml and under argon atmosphere in the literature (Tetrah
edron Letters, Volume 27, 3697
Page, 1986) prepared by the method described in Li 2 CuC.
Tetrahydrofuran solution of l 4 (1 mol / l) 0.29
ml was added, and the mixture was stirred at room temperature for 1.5 hours. Ethyl acetate was added to the reaction solution, which was washed successively with water and saturated saline and then dried over anhydrous magnesium sulfate. The crude product obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography [eluting with methylene chloride: acetone = 6: 1 (V / V)] to give colorless amorphous (34) as 0. 0.063 g (yield 97.0%) was obtained.

【0096】IR(KBr)cm-1:3403,2952,2868,1
713,1446,10651 H−NMR(CDCl3)δ:0.94(3H,d,J=5Hz),0.95
(3H,s),0.98(3H,d,J=5Hz),1.02(3H,s),3.43(1H,dd,J=11
and 5Hz),3.88(2H,s),3.90〜4.10(1H,m) FABMS m/z:455(MH+)。
IR (KBr) cm -1 : 3403,2952,2868,1
713,1446,1065 1 H-NMR (CDCl 3 ) δ: 0.94 (3H, d, J = 5Hz), 0.95
(3H, s), 0.98 (3H, d, J = 5Hz), 1.02 (3H, s), 3.43 (1H, dd, J = 11
and 5Hz), 3.88 (2H, s), 3.90-4.10 (1H, m) FABMS m / z: 455 (MH <+> ).

【0097】32)化合物(35)の合成 化合物(12)0.050gを塩化メチレン3.0mlに
溶解し、N,N−ジエチルグリシンナトリウム塩0.02
7g、4−ジメチルアミノピリジン0.007g及び1
−(3−ジメチルアミノプロピル)−3−エチルカルボ
ジイミド塩酸塩0.046gを加え、室温にて18時間
撹拌した。反応液に酢酸エチルを加え、水及び飽和食塩
水にて順次洗浄後、無水硫酸ナトリウムにて乾燥した。
溶媒を減圧留去して得られた粗生成物をシリカゲルカラ
ムクロマトグラフィー[酢酸エチル:メタノール=1
0:1(V/V)にて溶出]に付し、無色カラメル状物
質(35)を0.050g(収率78.7%)得た。
32) Synthesis of Compound (35) 0.050 g of Compound (12) was dissolved in 3.0 ml of methylene chloride, and N, N-diethylglycine sodium salt 0.02 was dissolved.
7 g, 4-dimethylaminopyridine 0.007 g and 1
-(3-Dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (0.046 g) was added, and the mixture was stirred at room temperature for 18 hours. Ethyl acetate was added to the reaction solution, which was washed successively with water and saturated saline and then dried over anhydrous sodium sulfate.
The crude product obtained by distilling off the solvent under reduced pressure was subjected to silica gel column chromatography [ethyl acetate: methanol = 1.
Elution with 0: 1 (V / V)] to obtain 0.050 g (yield 78.7%) of a colorless caramel-like substance (35).

【0098】IR(KBr)cm-1:3435,2955,1742,1
714,11591 H−NMR(CDCl3)δ:0.70(3H,s),0.90(3H,d,J
=7Hz),0.96(3H,d,J=7Hz),1.00(3H,s),1.05(6H,t,J=7H
z),2.66(4H,q,J=7Hz),2.73(1H,d,J=4Hz),3.08(1H,d,J=4
Hz),3.40〜3.30(1H,m),3.34(2H,s),4.22(1H,s),4.95(1
H,dd,J=10 and 3Hz) LSIMS m/z:532(MH+)。
IR (KBr) cm -1 : 3435, 2955, 1742, 1
714,1159 1 H-NMR (CDCl 3 ) δ: 0.70 (3H, s), 0.90 (3H, d, J
= 7Hz), 0.96 (3H, d, J = 7Hz), 1.00 (3H, s), 1.05 (6H, t, J = 7H
z), 2.66 (4H, q, J = 7Hz), 2.73 (1H, d, J = 4Hz), 3.08 (1H, d, J = 4
Hz), 3.40-3.30 (1H, m), 3.34 (2H, s), 4.22 (1H, s), 4.95 (1
H, dd, J = 10 and 3 Hz) LSIMS m / z: 532 (MH + ).

【0099】33)化合物(36)の合成 化合物(35)0.050gを酢酸エチル5.0mlに溶
解した溶液に、室温にて撹拌下、4規定塩化水素酢酸エ
チル溶液0.5mlを加えた。溶媒を減圧下留去して無
色非晶質(36)を0.051g(収率90.0%)得
た。
33) Synthesis of compound (36) To a solution of 0.050 g of compound (35) in 5.0 ml of ethyl acetate was added 0.5 ml of 4N hydrogen chloride ethyl acetate solution with stirring at room temperature. The solvent was distilled off under reduced pressure to obtain colorless amorphous (36) (0.051 g, yield 90.0%).

【0100】IR(KBr)cm-1:3236,2952,1750,1
712,12201 H−NMR(DMSO−d6)δ:0.85(3H,s),0.86(3
H,d,J=7Hz),0.95(3H,d,J=7Hz),0.96(3H,s),1.22(6H,t,J
=7Hz),3.10〜3.40(5H,m),4.20〜4.40(2H,m),5.37(1H,d,
J=10Hz),6.31(1H,d,J=3Hz),6.85(1H,s),10.10(1H,brs) LSIMS m/z:568[(M−HCl)H+]。
IR (KBr) cm -1 : 3236,2952,1750,1
712,1220 1 H-NMR (DMSO-d 6 ) δ: 0.85 (3H, s), 0.86 (3
H, d, J = 7Hz), 0.95 (3H, d, J = 7Hz), 0.96 (3H, s), 1.22 (6H, t, J
= 7Hz), 3.10 ~ 3.40 (5H, m), 4.20 ~ 4.40 (2H, m), 5.37 (1H, d,
J = 10Hz), 6.31 (1H, d, J = 3Hz), 6.85 (1H, s), 10.10 (1H, brs) LSIMS m / z: 568 [(M-HCl) H + ].

【0101】34)化合物(37)の合成 化合物(20)0.063gを塩化メチレン3.0mlに
溶解し、N,N−ジメチルグリシン0.036g、4−ジ
メチルアミノピリジン0.018g及び1−(3−ジメ
チルアミノプロピル)−3−エチルカルボジイミド塩酸
塩0.080gを加え、室温にて16時間撹拌した。反
応液に酢酸エチルを加え、水及び飽和食塩水にて順次洗
浄後、無水硫酸ナトリウムにて乾燥した。溶媒を減圧留
去して得られた粗生成物をシリカゲルカラムクロマトグ
ラフィー[酢酸エチル:メタノール=10:1(V/
V)にて溶出]に付し、無色カラメル状物質(37)を
0.063g(収率71.2%)得た。
34) Synthesis of compound (37) 0.063 g of compound (20) was dissolved in 3.0 ml of methylene chloride, and 0.036 g of N, N-dimethylglycine, 0.018 g of 4-dimethylaminopyridine and 1- ( 3-Dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (0.080 g) was added, and the mixture was stirred at room temperature for 16 hours. Ethyl acetate was added to the reaction solution, which was washed successively with water and saturated saline and then dried over anhydrous sodium sulfate. The crude product obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography [ethyl acetate: methanol = 10: 1 (V /
Elution with V)] to obtain 0.063 g (yield 71.2%) of a colorless caramel-like substance (37).

【0102】IR(KBr)cm-1:3438,2952,2872,1
746,1468,1198,11501 H−NMR(CDCl3)δ:0.67(3H,s),0.82(3H,s),
0.91(3H,d,J=5Hz),0.94(3H,d,J=5Hz),2.34(6H,s),2.36
(6H,s),2.72(1H,d,J=4Hz),3.08(1H,d,J=4Hz),3.14(2H,
s),3.20(2H,s),3.33(1H,dd,J=11 and 5Hz),4.17(1H,b
rs),4.69〜4.88(1H,m),4.97(1H,dd,J=10 and 4Hz) FABMS(+KI) m/z:629(MK+)。
IR (KBr) cm -1 : 3438,2952,2872,1
746,1468,1198,1150 1 H-NMR (CDCl 3 ) δ: 0.67 (3H, s), 0.82 (3H, s),
0.91 (3H, d, J = 5Hz), 0.94 (3H, d, J = 5Hz), 2.34 (6H, s), 2.36
(6H, s), 2.72 (1H, d, J = 4Hz), 3.08 (1H, d, J = 4Hz), 3.14 (2H,
s), 3.20 (2H, s), 3.33 (1H, dd, J = 11 and 5Hz), 4.17 (1H, b
rs), 4.69-4.88 (1H, m), 4.97 (1H, dd, J = 10 and 4Hz) FABMS (+ KI) m / z: 629 (MK + ).

【0103】35)化合物(38)の合成 化合物(20)0.360gを塩化メチレン15mlに
溶解し、N,N−ジエチルグリシンナトリウム塩0.38
0g、4−ジメチルアミノピリジン0.100g及び1
−(3−ジメチルアミノプロピル)−3−エチルカルボ
ジイミド塩酸塩0.640gを加え、室温にて8.5時間
撹拌した。反応液に酢酸エチルを加え、水及び飽和食塩
水にて順次洗浄後、無水硫酸ナトリウムにて乾燥した。
溶媒を減圧留去して得られた粗生成物をシリカゲルカラ
ムクロマトグラフィー[酢酸エチル:メタノール=9:
1(V/V)にて溶出]に付し、無色カラメル状物質
(38)を0.461g(収率85.7%)得た。
35) Synthesis of compound (38) 0.360 g of compound (20) was dissolved in 15 ml of methylene chloride, and N, N-diethylglycine sodium salt 0.38 was dissolved.
0 g, 4-dimethylaminopyridine 0.100 g and 1
0.640 g of-(3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride was added, and the mixture was stirred at room temperature for 8.5 hours. Ethyl acetate was added to the reaction solution, which was washed successively with water and saturated saline and then dried over anhydrous sodium sulfate.
The crude product obtained by evaporating the solvent under reduced pressure was subjected to silica gel column chromatography [ethyl acetate: methanol = 9:
1 (V / V) for elution] to obtain 0.461 g (yield 85.7%) of a colorless caramel-like substance (38).

【0104】IR(KBr)cm-1:3436,2965,1739,1
470,1453,1386,11851 H−NMR(CDCl3)δ:0.66(3H,s),0.81(3H,s),
0.90(3H,d,J=5Hz),0.94(3H,d,J=5Hz),1.05(12H,t,J=7H
z),2.50〜2.77(9H,m),3.06(1H,d,J=4Hz),3.21〜3.40(1
H,m),3.26(2H,s),3.34(2H,s),4.65〜4.85(1H,m),4.85〜
5.00(1H,m) LSIMS m/z:647(MH+)。
IR (KBr) cm -1 : 3436, 2965, 1739, 1
470,1453,1386,1185 1 H-NMR (CDCl 3 ) δ: 0.66 (3H, s), 0.81 (3H, s),
0.90 (3H, d, J = 5Hz), 0.94 (3H, d, J = 5Hz), 1.05 (12H, t, J = 7H
z), 2.50 to 2.77 (9H, m), 3.06 (1H, d, J = 4Hz), 3.21 to 3.40 (1
H, m), 3.26 (2H, s), 3.34 (2H, s), 4.65〜4.85 (1H, m), 4.85〜
5.00 (1H, m) LSIMS m / z: 647 (MH + ).

【0105】36)化合物(39)の合成 化合物(37)0.206gを酢酸エチル10mlに溶
解した溶液に、室温にて撹拌下、1規定塩化水素酢酸エ
チル溶液1.74mlを加えた。生じた沈殿をろ取し、
ジエチルエーテルにて洗浄して無色粉末(39)を0.
217g(収率88.9%)得た。
36) Synthesis of Compound (39) To a solution prepared by dissolving 0.206 g of Compound (37) in 10 ml of ethyl acetate, 1.74 ml of 1N hydrogen chloride-ethyl acetate solution was added with stirring at room temperature. The resulting precipitate is collected by filtration,
The colorless powder (39) was washed with diethyl ether to 0.
217 g (yield 88.9%) was obtained.

【0106】mp:176〜179℃ IR(KBr)cm-1:3420,2956,1746,1470,1368,123
2,10061 H−NMR(DMSO−d6)δ:0.79(3H,s),0.82(3
H,s),0.89(3H,d,J=5Hz),0.92(3H,d,J=5Hz),2.81(6H,s),
2.86(6H,s),3.28(1H,dd,J=11 and 4Hz),3.69(1H,d,J=11
Hz),3.87(1H,d,J=11Hz),4.15(2H,s),4.30(1H,d,J=17H
z),4.45(1H,d,J=17Hz),4.65〜4.85(1H,m),5.37(1H,d,J=
10Hz),6.46(1H,brs,exchangeable),6.94(1H,brs,exchan
geable),10.52(2H,brs,exchangeable) FABMS m/z:627[(M−2HCl)H+]。
Mp: 176-179 ° C IR (KBr) cm -1 : 3420,2956,1746,1470,1368,123
2,1006 1 H-NMR (DMSO-d 6 ) δ: 0.79 (3H, s), 0.82 (3
H, s), 0.89 (3H, d, J = 5Hz), 0.92 (3H, d, J = 5Hz), 2.81 (6H, s),
2.86 (6H, s), 3.28 (1H, dd, J = 11 and 4Hz), 3.69 (1H, d, J = 11
Hz), 3.87 (1H, d, J = 11Hz), 4.15 (2H, s), 4.30 (1H, d, J = 17H
z), 4.45 (1H, d, J = 17Hz), 4.65-4.85 (1H, m), 5.37 (1H, d, J =
10Hz), 6.46 (1H, brs, exchangeable), 6.94 (1H, brs, exchan
geable), 10.52 (2H, brs, exchangeable) FABMS m / z: 627 [(M-2HCl) H <+ >].

【0107】37)化合物(40)の合成 化合物(38)0.155gを酢酸エチル3.0mlに溶
解した溶液に、室温にて撹拌下、4規定塩化水素酢酸エ
チル溶液0.5mlを加えた。溶媒を減圧下留去して無
色粉末(40)を0.170g(収率97.1%)得た。
37) Synthesis of compound (40) To a solution of 0.155 g of compound (38) dissolved in 3.0 ml of ethyl acetate, 0.5 ml of 4N hydrogen chloride ethyl acetate solution was added with stirring at room temperature. The solvent was distilled off under reduced pressure to obtain 0.170 g (yield 97.1%) of colorless powder (40).

【0108】mp:150〜156℃ IR(KBr)cm-1:3216,2952,2584,1748,1470,122
41 H−NMR(CDCl3)δ:0.84(3H,s),0.90(3H,s),
0.94(3H,d,J=7Hz),0.96(3H,d,J=7Hz),1.45(12H,t,J=8H
z),3.20〜3.55(9H,m),3.85(4H,s),3.92(1H,d,J=17Hz),
4.21(1H,d,J=17Hz),4.70〜4.93(1H,m),5.54(1H,d,J=7H
z) LSIMS m/z:683[(M−HCl)H+]。
Mp: 150-156 ° C IR (KBr) cm -1 : 3216,2952,2584,1748,1470,122
4 1 H-NMR (CDCl 3 ) δ: 0.84 (3H, s), 0.90 (3H, s),
0.94 (3H, d, J = 7Hz), 0.96 (3H, d, J = 7Hz), 1.45 (12H, t, J = 8H
z), 3.20 ~ 3.55 (9H, m), 3.85 (4H, s), 3.92 (1H, d, J = 17Hz),
4.21 (1H, d, J = 17Hz), 4.70 ~ 4.93 (1H, m), 5.54 (1H, d, J = 7H
z) LSIMS m / z: 683 [(M-HCl) H + ].

【0109】38)化合物(41)及び化合物(42)
の合成 化合物(30)0.120gを塩化メチレン4.2mlに
溶解し、N,N−ジメチルグリシン0.050g、4−ジ
メチルアミノピリジン0.028g及び1−(3−ジメ
チルアミノプロピル)−3−エチルカルボジイミド塩酸
塩0.125gを加え、室温にて18.5時間撹拌した。
反応液に酢酸エチルを加え、水及び飽和食塩水にて順次
洗浄後、無水硫酸マグネシウムにて乾燥した。溶媒を減
圧留去して得られた残渣をシリカゲルフラッシュカラム
クロマトグラフィー[酢酸エチル:メタノール=30:
1(v/v)にて溶出]に付し、先に溶出する画分から
無色粉末(41)を0.066g(収率45.8%)、後
から溶出する画分から無色非晶質(42)を0.067
g(収率39.6%)得た。
38) Compound (41) and Compound (42)
Synthesis of compound (30) (0.120 g) was dissolved in methylene chloride (4.2 ml), N, N-dimethylglycine (0.050 g), 4-dimethylaminopyridine (0.028 g) and 1- (3-dimethylaminopropyl) -3- Ethylcarbodiimide hydrochloride (0.125 g) was added, and the mixture was stirred at room temperature for 18.5 hours.
Ethyl acetate was added to the reaction solution, which was washed successively with water and saturated saline and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the obtained residue was subjected to silica gel flash column chromatography [ethyl acetate: methanol = 30:
1 (v / v)], and 0.066 g (yield 45.8%) of colorless powder (41) from the fraction eluted earlier, and colorless amorphous (42) from the fraction eluted later. ) To 0.067
g (yield 39.6%) was obtained.

【0110】化合物(41) mp:71〜75℃ IR(KBr)cm-1:3432,2928,1748,1470,1198,116
41 H−NMR(CDCl3)δ:0.68(3H,s),0.78(3H,s),
0.93(3H,d,J=7Hz),0.95(3H,d,J=7Hz),2.38(6H,s),2.73
(1H,d,J=4Hz),3.10(1H,d,J=4Hz),3.21(2H,s),3.34(1H,d
d,J=11 and 5Hz),4.06(1H,brs),4.98(1H,dd,J=9 and 4H
z) FABMS(+KI) m/z:544(MK+)。
Compound (41) mp: 71 to 75 ° C. IR (KBr) cm −1 : 3432,2928,1748,1470,1198,116
4 1 H-NMR (CDCl 3 ) δ: 0.68 (3H, s), 0.78 (3H, s),
0.93 (3H, d, J = 7Hz), 0.95 (3H, d, J = 7Hz), 2.38 (6H, s), 2.73
(1H, d, J = 4Hz), 3.10 (1H, d, J = 4Hz), 3.21 (2H, s), 3.34 (1H, d
d, J = 11 and 5Hz), 4.06 (1H, brs), 4.98 (1H, dd, J = 9 and 4H
z) FABMS (+ KI) m / z: 544 (MK + ).

【0111】化合物(42) IR(KBr)cm-1:3446,2952,2872,2772,1746,146
8,1202,1150,10661 H−NMR(CDCl3)δ:0.67(3H,s),0.78(3H,s),
0.89(3H,d,J=6Hz),0.94(3H,d,J=6Hz),2.36(6H,s),2.37
(6H,s),2.72(1H,d,J=4Hz),3.07(1H,d,J=4Hz),3.17(2H,
s),3.19(2H,s),3.33(1H,dd,J=11 and 5Hz),4.16(1H,br
s),4.96(1H,dd,J=10 and 4Hz),5.10(1H,brs) FABMS(+KI) m/z:629(MK+)。
Compound (42) IR (KBr) cm −1 : 3446,2952,2872,2772,1746,146
8,1202,1150,1066 1 H-NMR (CDCl 3 ) δ: 0.67 (3H, s), 0.78 (3H, s),
0.89 (3H, d, J = 6Hz), 0.94 (3H, d, J = 6Hz), 2.36 (6H, s), 2.37
(6H, s), 2.72 (1H, d, J = 4Hz), 3.07 (1H, d, J = 4Hz), 3.17 (2H,
s), 3.19 (2H, s), 3.33 (1H, dd, J = 11 and 5Hz), 4.16 (1H, br
s), 4.96 (1H, dd, J = 10 and 4Hz), 5.10 (1H, brs) FABMS (+ KI) m / z: 629 (MK + ).

【0112】39)化合物(43)の合成 化合物(41)0.028gを酢酸エチル2.0mlに溶
解した溶液に、室温にて撹拌下、1規定塩化水素酢酸エ
チル溶液0.11mlを加えた。溶媒を減圧下留去して
無色粉末(43)を0.029g(収率90.6%)得
た。
39) Synthesis of compound (43) To a solution of 0.028 g of compound (41) in 2.0 ml of ethyl acetate was added 0.11 ml of 1N hydrogen chloride ethyl acetate solution with stirring at room temperature. The solvent was evaporated under reduced pressure to obtain 0.029 g (yield 90.6%) of colorless powder (43).

【0113】mp:168〜172℃ IR(KBr)cm-1:3420,2926,1752,1232,10041 H−NMR(CDCl3)δ:0.78(3H,s),0.89(3H,s),
0.96(3H,d,J=6Hz),0.98(3H,d,J=6Hz),3.07(6H,s),3.35
〜3.52(1H,m),3.82(2H,s),4.04(1H,brs),4.00〜4.18(1
H,m),4.50〜4.68(1H,m),5.59(1H,d,J=10Hz) FABMS(+KI) m/z:580[(M−HC
l)K+]。
Mp: 168 to 172 ° C. IR (KBr) cm −1 : 3420,2926,1752,1232,1004 1 H-NMR (CDCl 3 ) δ: 0.78 (3H, s), 0.89 (3H, s),
0.96 (3H, d, J = 6Hz), 0.98 (3H, d, J = 6Hz), 3.07 (6H, s), 3.35
~ 3.52 (1H, m), 3.82 (2H, s), 4.04 (1H, brs), 4.00 ~ 4.18 (1
H, m), 4.50-4.68 (1H, m), 5.59 (1H, d, J = 10Hz) FABMS (+ KI) m / z: 580 [(M-HC
l) K + ].

【0114】40)化合物(44)の合成 化合物(42)0.026gを酢酸エチル2.0mlに溶
解した溶液に、室温にて撹拌下、1規定塩化水素酢酸エ
チル溶液0.132mlを加えた。溶媒を減圧下留去し
て無色粉末(44)を0.031g(収率100%)得
た。
40) Synthesis of compound (44) To a solution of 0.026 g of compound (42) in 2.0 ml of ethyl acetate was added 0.132 ml of 1N hydrogen chloride ethyl acetate solution with stirring at room temperature. The solvent was distilled off under reduced pressure to obtain 0.031 g (yield 100%) of colorless powder (44).

【0115】mp:199〜203℃ IR(KBr)cm-1:3418,2934,1746,1470,1368,123
41 H−NMR(DMSO−d6)δ:0.78(3H,s),0.82(3
H,s),0.90(3H,d,J=6Hz),0.93(3H,d,J=6Hz),2.82(6H,s),
2.85(6H,s),3.21〜3.32(1H,m),3.68(1H,d,J=11Hz),3.87
(1H,d,J=11Hz),4.18(2H,s),4.29(1H,d,J=16Hz),4.43(1
H,d,J=16Hz),5.09(1H,brs),5.37(1H,d,J=10Hz),6.44(1
H,brs,exchangeable),6.94(1H,s,exchangeable),10.48
(2H,brs,exchangeable) FABMS(+KI) m/z:665[(M−2HC
l)K+]。
Mp: 199-203 ° C IR (KBr) cm -1 : 3418,2934,1746,1470,1368,123
4 1 H-NMR (DMSO-d 6 ) δ: 0.78 (3H, s), 0.82 (3
H, s), 0.90 (3H, d, J = 6Hz), 0.93 (3H, d, J = 6Hz), 2.82 (6H, s),
2.85 (6H, s), 3.21〜3.32 (1H, m), 3.68 (1H, d, J = 11Hz), 3.87
(1H, d, J = 11Hz), 4.18 (2H, s), 4.29 (1H, d, J = 16Hz), 4.43 (1
H, d, J = 16Hz), 5.09 (1H, brs), 5.37 (1H, d, J = 10Hz), 6.44 (1
H, brs, exchangeable), 6.94 (1H, s, exchangeable), 10.48
(2H, brs, exchangeable) FABMS (+ KI) m / z: 665 [(M-2HC
l) K + ].

【0116】以下に試験例を挙げて本発明の有用性を示
す。 試験例 KB細胞に対する増殖阻害作用(In vitro) 1)試験方法 平底の96穴プレートの各穴にKB細胞1×103個/
0.1mlの細胞浮遊液(10%牛胎児血清添加MEM
培地に浮遊)を添加し24時間培養した。これに、ジメ
チルスルホキシドに溶解し、培地で希釈した被験化合物
液100μl(ジメチルスルホキシド最終濃度0.5
%)を添加し、さらに72時間培養した。培養後、4,
5−ジメチルチアゾール−2−イル−2,5−ジフェニ
ルテトラゾリウム ブロマイド試薬(発色試薬)を添加
し、さらに4時間培養した。
The usefulness of the present invention will be shown below with reference to test examples. Test Example Proliferation Inhibitory Effect on KB Cells (In Vitro) 1) Test Method 1 × 10 3 KB cells / well in each flat-bottom 96-well plate
0.1 ml of cell suspension (MEM containing 10% fetal bovine serum)
(Floating in the medium) and cultured for 24 hours. To this, 100 μl of a test compound solution dissolved in dimethylsulfoxide and diluted with a medium (dimethylsulfoxide final concentration: 0.5)
%) Was added and the cells were further cultured for 72 hours. After culture,
A 5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide reagent (coloring reagent) was added, and the cells were further cultured for 4 hours.

【0117】コントロールとして培地100μl(ジメ
チルスルホキシド最終濃度0.5%)を添加し、同様に
培養した。培養終了後、培地を除き、細胞を150μl
のジメチルスルホキシドに溶解して吸光度を測定し、コ
ントロール群の吸光度に対する被験化合物群の吸光度の
比を求め、50%増殖阻害濃度(IC50)を計算した。
As a control, 100 μl of medium (final concentration of dimethyl sulfoxide was 0.5%) was added, and the cells were cultured in the same manner. After culturing, remove the medium and add 150 μl of cells.
Was dissolved in dimethylsulfoxide and the absorbance was measured, the ratio of the absorbance of the test compound group to the absorbance of the control group was determined, and the 50% growth inhibitory concentration (IC 50 ) was calculated.

【0118】2)試験結果 被験化合物[実施例31に記載の化合物(34)及び化
合物C]のKB細胞に対するIC50を表1に示した。
2) Test Results Table 1 shows the IC 50 of the test compounds [compound (34) and compound C described in Example 31] to KB cells.

【0119】[0119]

【表1】 [Table 1]

フロントページの続き (72)発明者 山田 泰司 東京都八王子市南陽台2−18−12Continued Front Page (72) Inventor Taiji Yamada 2-18-12 Nanyodai, Hachioji, Tokyo

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 式 【化1】 (式中、Rは炭素原子数1〜13のアルキル基を示し、
Aは水酸基または容易に加水分解されて水酸基になる基
を示し、XとYは一緒になってオキソ基又は炭素原子数
2もしくは3のアルキレンジオキシ基を示すか、X及び
Yはそれぞれ水素原子、水酸基、炭素原子数1〜5のア
ルコキシ基又は容易に加水分解されて水酸基になる基を
示す。但し、Xが水酸基又は容易に加水分解されて水酸
基になる基のときYは水素原子であり、Yが水酸基又は
容易に加水分解されて水酸基になる基のときXは水素原
子である。また、Xが炭素原子数1〜5のアルコキシ基
のときYは炭素原子数1〜5のアルコキシ基である。)
で表わされるステロイド誘導体及びその医薬上許容され
る塩。
(1) Formula (1) (In the formula, R represents an alkyl group having 1 to 13 carbon atoms,
A represents a hydroxyl group or a group which is easily hydrolyzed to a hydroxyl group, X and Y together represent an oxo group or an alkylenedioxy group having 2 or 3 carbon atoms, or X and Y are each a hydrogen atom. , A hydroxyl group, an alkoxy group having 1 to 5 carbon atoms, or a group which is easily hydrolyzed to form a hydroxyl group. However, Y is a hydrogen atom when X is a hydroxyl group or a group which is easily hydrolyzed to a hydroxyl group, and X is a hydrogen atom when Y is a hydroxyl group or a group which is easily hydrolyzed to a hydroxyl group. When X is an alkoxy group having 1 to 5 carbon atoms, Y is an alkoxy group having 1 to 5 carbon atoms. )
And a pharmaceutically acceptable salt thereof.
JP8115165A 1995-06-12 1996-05-10 Steroid derivative Pending JPH0959295A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8115165A JPH0959295A (en) 1995-06-12 1996-05-10 Steroid derivative

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP14469595 1995-06-12
JP7-144695 1995-06-12
JP8115165A JPH0959295A (en) 1995-06-12 1996-05-10 Steroid derivative

Publications (1)

Publication Number Publication Date
JPH0959295A true JPH0959295A (en) 1997-03-04

Family

ID=26453736

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8115165A Pending JPH0959295A (en) 1995-06-12 1996-05-10 Steroid derivative

Country Status (1)

Country Link
JP (1) JPH0959295A (en)

Similar Documents

Publication Publication Date Title
JPS5854160B2 (en) Method for producing 1α,3β-dihydroxysteroid-5-ene or its derivative
US4310467A (en) Process and intermediates for the synthesis of vitamin D3 metabolites
Chowdhury et al. A simple efficient process for the synthesis of 16-dehydropregnenolone acetate (16-DPA)–a key steroid drug intermediate from diosgenin
EP0080381B1 (en) Homobrassinolide, and its production and use
CN115884978A (en) Process for preparing cholic acid derivatives and starting materials therefor
JP3453188B2 (en) Method for producing oleanolic acid derivative
JP7146067B2 (en) Preparation of Intermediates Useful for Synthesis of SGLT Inhibitors
CN111138276A (en) Synthesis method of chiral 5- (4-fluorophenyl) -5-hydroxypentanoate
WO2008093853A1 (en) Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same
EP0735047B1 (en) Sterol epoxides for cancer treatment
JPH0959295A (en) Steroid derivative
JPH0121146B2 (en)
JPH08333386A (en) Steroid derivative
JPH07224087A (en) Steroid derivative
EP1688409B1 (en) Vitamin d-derived monohalogenovinyl compounds
CN114057684B (en) Synthesis method of tiotropium bromide intermediate methyl bis (2-dithienyl) glycolate
JP3682291B2 (en) Method for producing oleanolic acid derivative
JP2016527213A (en) Method for producing abiraterone acetate
JPS6345249A (en) Fluorine derivative of activated vitamin d3
JP2879776B2 (en) Method for producing active vitamin D derivative
JPH0616667A (en) New production of pyrazolo(1,5-a)pyridine derivative
US20220298202A1 (en) Methods of making cholic acid derivatives and starting materials therefor
US4939247A (en) Gamma-lactone derivatives and process of preparing same
JPH10251294A (en) Cis-sterol compound
JP3759636B2 (en) Pregnane derivative and process for producing the same